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1. Abstract 
 
In folklore and natural medicine, American cranberry is believed to be active in the 
prevention and treatment of urinary tract infections (UTIs). Clinical studies show a 
correlation of cranberry juice consumption and decreased occurrence of UTIs. Becoming 
important for the maintenance of human health, the quality of cranberry juice has to be 
monitored and assured. In the present work, a profile of the phenolic secondary metabolites 
of a Vaccinium macrocarpon extract, which seem to be the bioactive compounds, was 
established, using NMR spectrometry. Subsequently, cranberry juice samples of four 
different brands were analyzed by NMR in combination with multivariate data analysis. 
The analyzed juices showed differences depending on the manufacturer mostly by the 
concentrations of benzoic acid, benzoic acid glucoside, quercetin and catechin present in 
the juice. 
 
In der Naturheilkunde wird Vaccinium macrocarpon (Großfrüchtige Moosbeere, 
„Cranberry“, Kultur-Preiselbeere) als Mittel zur Prophylaxe und Behandlung von 
Harnwegsentzündungen verwendet. Klinische Studien belegen eine positive Korrelation 
zwischen regelmäßigem (täglichen) Konsum von Cranberrysaft und geringerer Häufigkeit 
von Harnwegsentzündungen.  Wird der Cranberrysaft aufgrund seiner Wirkung als 
gesundheitsförderndes Nahrungsergänzungsmittel konsumiert, sollte eine 
Qualitätskontrolle der bioaktiven Inhaltsstoffe, der phenolischen Sekundärmetaboliten, 
erfolgen. Im Rahmen dieser Arbeit wurde mithilfe von NMR-Spektroskopie ein Profil der 
phenolischen Sekundärmetaboliten in einem Vaccinium-macrocarpon-Extrakt erstellt. 
Anschließend wurden Cranberrysäfte von vier Herstellern mittels NMR-Spektroskopie 
untersucht und die Daten einer Multivariaten Datenanalyse unterworfen. Die untersuchten 
Cranberrysäfte zeigten unterschiedliche Konzentrationen von Benzoesäure, Benzoesäure-
Glucosid, Quercetin und Catechin. 
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2. Introduction and Objectives 
American cranberry (Vaccinium macrocarpon Ait.) is a low-growing perennial shrub, 
native to North America. It´s fruits, “cranberries”, can be consumed as fresh fruits or in 
different preparations, such as juice cocktails, jams, sauces or relish. Folklore ascribes 
multiple health-promoting properties to cranberry, most famously, a preventive effect 
against urinary tract infections (UTI). In the recent years, several studies were conducted to 
investigate this effect (Bailey et al., 2007; McMurdo et al., 2005; Kontiokari et al., 2001). 
Cranberry extract has been shown to inhibit the adherence of uropathogenic Escherichia 
coli to urinary tract epithelial cells in vitro (Zafriri et al., 1989). Unique A-type linked 
proanthocyanidins (condensed tannins) and fructose were determined as the bioactive 
compounds (Foo et al., 2000). A recent review (Jepson and Craig, 2007) concludes, that 
there is positive clinical evidence for the UTI-preventive effect provided by regular 
cranberry juice consumption, although it seems that only in certain subpopulations. 
Urinary tract infections represent a major problem and were shown to be more prevalent 
among women than men, throughout all age groups. It has been estimated that around 25% 
of women have had at least one UTI in their lifetime and will suffer several (Henig and 
Leahy, 2000). With the increasing numbers of resistant bacteria to the antibiotic agents in 
use, the focus is increasingly drawn to the prevention of urinary tract infections and the 
role of cranberry therein. According to current knowledge, daily dosages of 240 – 300 ml 
of cranberry juice cocktail are recommended for the prevention of UTIs (Howell, 2007). In 
this way, cranberry juice cocktail is becoming a medical product and plays a role in the 
contribution to and preservation of human health, therefore its quality has to be controlled, 
unified and guaranteed. A metabolomics approach to establish a quality control of 
cranberry juice cocktail, offers a good method to monitor the quality and quantity of 
(secondary) metabolites, which are directly linked to the health-beneficial effects exerted. 
The use of NMR provides a macroscopic observation of a broad range of compounds 
(metabolites) present in cranberry juice cocktail, which allows to detect poor quality or 
adulteration in respect to different criteria (quality/quantity of proanthocyanidins, addition 
of preservatives or sugar etc.).  
 
The specific objective of the present work consists of: 
1. profile of secondary metabolites in Vaccinium macrocarpon extract using NMR 
2. analysis of cranberry juices for the development of a quality control technique 
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To achieve the specific aims, an extract of Vaccinium macrocarpon was analyzed by 
one- and two-dimensional nuclear magnetic resonace spectrometry. Subsequently, samples 
of four different manufacturers of cranberry juice were analyzed using NMR, followed by 
multivariate data analysis. 
 
The next chapter gives an introduction in the field of “metabolomics”, followed by 
chapter 4, in which a closer look to the taxonomy and morphology of V. macrocarpon is 
taken and previous studies about its health-beneficial properties are discussed. Chapter 5 
deals with urinary tract infections, risk factors, treatment and prevention strategies. Chapter 
6 and 7 give a short introduction to the principle of nuclear magnetic resonance 
spectrometry and the basic theory of principal component analysis, respectively. In chapter 
8, materials and the physico-chemical methods used in the present work are summed up. 
Finally, results are summarized and discussed in chapter 10. 
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3. Metabolomics  
3.1 General term definition 
The term metabolomics can be defined as the aim of a qualitative and quantitative 
measurement of all low molecular weight metabolites in an organism at a specified time 
under specific environmental conditions (Colquhoun, 2007; Eisenreich and Bacher, 2007). 
The ultimate goal is to provide a broad and essentially non-targeted snapshot representing 
the greatly diverse composition of the plants metabolites (Hall, 2006). No absolute 
numbers are known, but it is estimated that an organism contains about the same quantity 
of compounds as it has genes. For plants the number would be around 30 000 compounds 
(Verpoorte et al., 2008). These compounds are present in a wide range of quantities 
(hormones vs. sugars) and show totally different chemical properties (lipids vs. sugars). By 
this complexity, plants can be defined at every level of genotype, phenotype, tissue and 
cell. This approach provides a deeper insight into the metabolic composition of plant 
tissues and the obtained data can be exploited effectively for both their diagnostic and 
predictive value (Hall, 2006).  
Generally, the metabolome (entity of small molecules in an organism) consists of two 
types of compounds - primary and secondary metabolites. Primary metabolites are 
responsible for the basic functions of living cells, such as respiration or amino acid 
biosynthesis. Basically, all organisms share the same type of primary metabolites, though 
per class of organisms large differences may result from different biosynthetic pathways 
(e.g. mammalians are not capable of amino acid biosynthesis). In contrast to this, 
secondary metabolites are species specific and  are involved in the interaction of cells with 
their surrounding environment (Verpoorte et al., 2007). The plant needs to compensate 
temporal and seasonal challenges, which is facilitated by metabolic changes. Therefore, 
plants have developed a complex arsenal of secondary metabolites to deal with abiotic 
(light, UV, water) and biotic (herbivores, parasitism and pathogen attack) stress factors 
(Hall, 2006). The primary metabolites are therefore important for the growth and 
agricultural yields, whereas the secondary metabolites are responsible for flavor, color and 
the resistance of plants against various stress factors (Verpoorte et al., 2007). It is also the 
secondary metabolites in our food that are linked to health-beneficial properties, provided 
by plants, such as are proanthocyanidins in cranberry or alkaloids in various plant species. 
Different approaches are in use for metabolite analysis. On the one hand, “metabolic 
fingerprinting” is a term defining a high throughput qualitative screening of the metabolic 
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composition of the analyzed sample, e.g. a plant tissue exract, with the primary aim of 
sample comparison and discrimination analysis. Generally, no attempt is initially made to 
identify the detected metabolites. Sample preparation, separation and detection should be 
as rapid and simple as possible. On the other hand, “metabolic profiling” represents the 
identification and quantification of the detected metabolites. For practical reasons this is 
only feasible for a limited number of compounds, which can be selected on the basis of 
analysis or molecular relationships in molecular pathways/networks. 
It is essential to consider that all metabolomic measurements result in a so-called 
“metabolic snapshot” which is specific to the time of sampling. The obtained information 
provide a valuable metabolic insight, but also puts emphasis to proper care of the 
cultivation and sampling of the analyzed material. Samples originating from different  
sources, collected at different times, etc. can be compared, but conclusions should be 
drawn in context of the initial sample differences (Hall, 2006). Metabolomics studies can 
be divided into three phases. In the first, as many signals as possible are assigned to 
compounds, followed by the second phase, in which a large number of samples is 
measured, e.g. young and old leaves, different times of the day, and different stages of 
development of the plant, to determine the biological variation for the system studied. In 
the third phase, the effect of different experimental conditions on the model system is 
studied, e.g. diseased or transgenic plants compared with the normal wild type (Verpoorte 
et al., 2007). 
Ultimately, metabolic analysis aims towards providing an efficient and comprehensive 
predictive tool for analyzing the performance of the complex metabolic network. 
Metabolic analysis seems to represent the key to predictive tools, which allow the detection 
of multiple metabolites and fluxes. The identification of components in a biological system 
is an essential first step towards explaining their biological function (Ratcliffe and 
Shachar-Hill, 2005). 
 
3.2 Analytical methods in use for metabolomics  
The main requirements for analytical methods employed for metabolomics purposes 
include a broad coverage of detected metabolites, qualitative and quantitative results, high 
reproducibility and signal robustness, as well as preferably short time for measurement  
(Choi, 2008). Five major approaches are currently employed for metabolomic analyses: 
HPLC- or TLC-UV, GC-MS, MSn and NMR-spectroscopy (Verpoorte et al., 2008). Mass 
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spectrometry (MS) and nuclear magnetic resonance spectrometry (NMR) are considered to 
be the primary, because most universal approaches among the available analytical tools 
(Verpoorte et al. 2007). The technologies applied in metabolomics show characteristic 
advantages and drawbacks considering the diversity of metabolites detected, sensitivity, or 
resolution (Verpoorte et al., 2008). The selection of the most suitable technique results in a 
compromise between speed, selectivity, and sensitivity. Usually, a first step of 
chromatographic separation is carried out before further analysis of the sample by GC or 
LC-MS (Mattoli et al., 2006). 
Currently, none of the techniques applied for metabolomic measurements is able to 
provide  complete qualitative and quantitative information of all the metabolites that are 
present in a tissue extract. The available methods either provide a metabolite “profile”, in 
which metabolites of a selected group are identified and quantified, or a metabolite 
“fingerprint”, in which metabolites are detected and subjected to pattern recognition 
analysis (Ratcliffe and Shachar-Hill, 2005).  
In the present work, the metabolomics data were acquired by NMR measurements, 
therefore the focus is mainly drawn to this method. The basic workflow, as well as the 
main advantages and challenges are discussed in chapter 6. 
 
3.3 Applications  
The increased information on the biochemical composition of plant tissues can be 
exploited in a wide range of both scientific and applied fields (Hall, 2006). One of the most 
established applications of plant metabolomics is the analysis of dynamic metabolite 
changes during stress (Guy et al., 2008). The most common use for plant metabolomics is 
comparative analysis. By application of multivariate data analysis, plants of different 
genotypes or plants subjected to different treatments, can be distinguished (Ratcliffe and 
Shachar-Hill, 2005). Metabolomics information provides a deeper insight into the complex 
and highly interactive nature of the plant metabolic network. It also contributes to a deeper 
understanding of the nature of plant phenotypes in relation to development, physiology and 
environment (Ward et al., 2007).  
The quality of crop plants is a direct function of their metabolite content. The quality of 
plant tissues also determines their commercial value in terms of factors, such as flavor, 
fragrance, shelf life, physical attributes, etc. Each of these attributes can be defined by a 
metabolic profile of the concerned material at a specific time. Metabolomic analysis can be 
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applied as an efficient tool to monitor crop quality or to identify potential biochemical 
markers, which enable the detection of product contamination and adulteration (Hall, 
2006). Metabolomics contributes to gaining a deeper knowledge and have better control of 
the biochemical basis of our food. This knowledge can be exploited to design modified 
programmes, which are aimed at better quality, optimised food processing and ultimately, 
improved (micro)nutrient bioavailability and bioefficacy. The understanding of pathways, 
which are responsible for the biosynthesis of nutritionally relevant metabolites is essential 
to gain control of the absence/level of presence of these compounds in our food . The 
identification of molecular markers can contribute future development of high quality food 
products (Hall et al., 2008).  
One of main aims of plant metabolic analyses is the development of a detailed view of 
the control hierarchy in the metabolic network. This knowledge would allow rational 
design of strategies to genetically engineer metabolism for the targeted overproduction of 
desirable end-products. However, these efforts have until now mosty failed. This might be 
explained by the fact, that the control of a metabolic pathway is generally shared among all 
enzymes of this pathway. Hence, engineering of a single enzyme is not likely to result in 
significant flux change. The goal is to generate a more complete view of the whole 
metabolic network, including a quantification of the control exerted by each enzyme, 
instead of dealing with individual pathways. Subsequently, the gene-regulatory network 
will be superimposed on the metabolic network model to account for the the consequences 
of altered environmental or developmental circumstances on the structure and balance of 
the metabolic network (Sweetlove et al., 2008).  
Another application of metabolomics is the determination of the extent and 
effectiveness of a modification introduced by genetic engineering. Genetically modified 
(GM) products are subjected to metabolic analysis to assess so-called “unintended effects”. 
In the highly interactive metabolic network, which is present in plant tissues, even minor 
changes have the potential to result in significant changes in nutritionally relevant 
metabolite content. On the one hand, metabolomics finds application in the investigation of 
the impact of environmental conditions (spatial/seasonal etc.) on food quality. On the other 
hand, it is also used for the development of tools and markers for quality monitoring. 
Nutrigenomics is a science trying to link nutrition and the genome. Metabolomics 
represents an integral component and is predicted to play an important role by correlating 
bioactive food metabolites and disease prevention. The aim would be a switch from single 
biomarkers to increasingly comprehensive (metabolomic) profiles. Metabolomics can be 
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applied to study the complex interaction between food production, processing, 
consumption and long-term health status and to provide both plant and human biomarkers. 
Metabolomics is currently finding application in exploring important biochemical 
pathways in plants. This information linked with knowledge of the genetics, can be 
exploited for the design of breeding programmes, which target to nutrition-related issues 
more closely (Hall et al., 2008). 
Metabolic NMR fingerprinting has been used for many years to authenticate foodstuffs, 
especially in the beverage industry (Brescia et al., 2002; Le Gall et al., 2001; Charlton et 
al., 2002; Duarte et al., 2002; Vogels et al., 1996). The quality control of phytomedicinal 
preparations is becoming increasingly important. In recent years, nutraceuticals and 
“bioprotective” or “functional” foods have attracted much attention. Increasing numbers of 
food products reach the market bearing health-related claims often focused on e.g. anti-
oxidant activity. The metabolomics approach is predicted to play an important role in this 
regard for both the plant and human sides (Hall et al., 2008). 
 
3.4 Limitations 
Currently, no single analytical technique is able to generate sufficient visualization of 
the metabolome, and multiple methodologies are therefore employed to gain a 
comprehensive view (Mattoli et al., 2006). All currently applied extraction and detection 
methods, have characteristic and unavoidable intrinsic bias towards certain metabolite 
groups, irrespective of their high level of sophistication (Hall, 2006). The major limitation 
of metabolomic analysis is the inability to completey profile the metabolome. Difficulties 
faced in this context are directly linked to the chemical complexity of the metabolic 
composition and the dynamic range limitations of most instrumental approaches (Mattoli et 
al., 2006). Hence, for comprehensive coverage multiparallel, complementary 
extraction/detection technology combinations using hyphenated systems can be employed 
to build up a metabolic picture towards an ever-increasing degree of completeness (Hall, 
2006). 
Major limitations also occur by the currently limited ability to chemically identify many 
of the detected compounds and the lack of reference compounds for these metabolites, 
which results in a major obstacle for their definite quantification. The quantification of 
discriminative components is essential when exploiting metabolic datasets beyond 
profiling and particularly when investigating the metabolic flux (Hall, 2006). Another 
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limitation is that the methodologies in use for metabolomic measurements require the 
analysis of plant tissue extracts. Ideally, metabolomics analyses would be performed at the 
cellular or subcellular level without extraction. This is of particular importantance, when 
analysing the metabolic flux. Currently, the total content of a metabolite is measured, 
which does not consider a potential physical separation within the cell (Hall, 2006; 
Sweetlove et al., 2008; Ratcliffe and Shachar-Hill, 2005).  
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4. Vaccinium macrocarpon Ait. 
4.1 Scientific classification 
Kingdom:   Plantae 
Division:   Magnoliophyta 
Class:    Magnoliopsida 
Order:    Ericales 
Family:   Ericaceae 
Genus:    Vaccinium L. 
Species:   Vaccinium macrocarpon Aiton 
Common names (engl.): American cranberry, large cranberry, cranberry 
 
4.2 Botanical description 
 
 
 
     Fig. 1. Vaccinium macrocarpon 
 
 
Vaccinium macrocarpon is a low-growing, trailing, woody shrub with a perennial habit. 
The plant produces stolons (horizontal stems), which can be up to 2 m long. Short vertical 
branches  or uprights, 5 to 20 cm long, grow from buds on the stolons and can be either 
vegetative or fruiting. Each fruiting upright contains up to seven flowers. The flowers, 
which are pink or pale rose colored, are tube-shaped in terminal clusters, and deeply 4-
parted. The lobes are lanceolate, reflexed and the anthers exserted, awnless. The flowers 
bloom in the  time from June – August and are pollinated primarily via domestic honey 
bees. The flowers are followed by a globous dark red edible fruit in the size of 12 – 20 mm 
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containing many seeds. The leaves are leathery, evergreen and the shape is elliptic to 
oblong (7 – 17 mm). During the growing season, the leaves are dark green and glossy, and 
turn reddish-brown during the dormant season. The habitus of Vaccinium oxycoccus 
(European cranberry) is very similar. The larger fruits (“cranberries”) of Vaccinium 
macrocarpon (American cranberry), however, represent the main differentiating 
morphologic factor between these two species, also indicated by the common name “large 
cranberry”. 
 
4.3 Habitat and distribution 
Vaccinium macrocarpon (American cranberry) is, as the name suggests, a native 
American heath. Its native range extends in temperate climate zones from the East Coast to 
the Central U.S. and from Southern Canada to the north to the Appalachians. The plants 
thrive on the special combination of soils and hydrology found in wetlands. American 
cranberry is cultivated for commercial purposes in sandy “bogs”, marshes or rain-soaked 
salt meadows in Massachusetts, New Jersey, and the Canadian provinces of Quebec and 
British columbia. Commercial harvests occur in September and October (Raz et al. 2004; 
Foo et al. 2000). 
 
 
 
      Fig. 2. Distribution of V. macrocarpon in North America 
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4.4 Medical effects 
4.4.1 History 
According to Native American legends and reports from European explorers, 
cranberries were extensively used by the Amerindians in their diet, medicine, and for 
commercial purposes. The fresh berries were ground into a damp meal containing meat or 
fish, which was subsequently sun dried to make pemmican, which is a dried meat to 
sustain travellers and hunters. Later, cranberries were discovered by American sailors as a 
remedy to prevent scurvy. Native Americans were the first to use cranberries for their 
medicinal properties. The fruits were used in poultices for treating wounds, blood 
poisoning (Henig and Leahy, 2000) and various other complaints, including stomach 
ailments, liver problems and fever (Raz et al., 2004). The plant leaves were used for 
urinary disorders, diarrhea, and diabetes (Henig and Leahy, 2000). 
In recent years, cranberry has gained strong public attention for its putative role in 
maintaining urinary tract health by prevention of infections. Particularly in the form of 
cranberry juice, it has been widely used for several decades for this purpose (Jepson and 
Craig, 2007). 
Cranberries can be consumed as fresh fruits, or processed into concentrate, sauce 
products, and juice drinks. The most common preparation is cranberry juice cocktail 
(CJC),  comprising a mixture of cranberry juice, sweetener, water, and added vitamin C 
(ascorbic acid). Also, dried cranberry powder formulated in capsules or tablets is available 
(Raz et al., 2004). 
 
4.4.2 Literature on biological activity of V. macrocarpon 
Throughout its range, Vaccinium macrocarpon is believed to provide with various 
health beneficial properties. Many studies were conducted to find scientific evidence for its 
putative effects. 
Phenolic cranberry compounds were shown to possess significant oxygen radical 
absorbing capacity (Zheng and Wang 2003; Määttä-Riihinen et al. 2005). It is suggested 
that potentially cancer-inducing oxidative damage might be balanced by dietary 
antioxidants. Therefore, berry extracts containing high amounts of flavonoids were tested 
for their ability to inhibit the growth of selected human tumor cell lines in vitro. With 
increasing concentration of cranberry extract, increasing inhibition of cell proliferation in 
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all of the cell lines tested could be observed, with different degrees of potency between cell 
lines (Seeram et al. 2006; Neto, 2007).  
Being a rich source of natural anthocyanin antioxidants, cranberries are reported to have 
positive influence on age-induced oxidative stress, inflammatory responses, and various 
degenerative diseases. Berry anthocyanins were also reported to improve neuronal and 
cognitive brain functions, ocular health, as well as protect genomic DNA integrity (Zafra-
Stone et al., 2007). 
Cranberry consumption is reported to provide cardioprotective benefits, including 
improvements in plasma lipids and vascular function, as well as reduction of the systemic 
and vascular inflammatory response (Ruel and Couillard, 2007; Comalada et al. 2005).  
A study shows that long-term fruit juice consumption might provide protection against 
Alzheimer´s disease. However, the protective effects may be enhanced by consumption of 
a combination of juices rich in phenolics, one of which being cranberry juice (Dai et al. 
2007).  
A study has found that a cranberry fraction inhibits colonization of oral streptococci to 
the tooth surface and might in this way slow the development of dental plaque, which is a 
major cause of peridontal and gum diseases (Yamanaka et al. 2004). It was also shown that 
high molecular weight compounds of cranberry possess an inhibitory effect on influenza 
virus adhesion and infectivity (Weiss et al. 2005).  
There is evidence for cranberry products indicating their positive effect in reducing 
urinary tract infections (Jepson and Craig, 2007). Being an important aspect of this work, 
the role of cranberry in the maintenance of urinary tract health is discussed in more detail 
in chapter 5.7.2. 
 
4.5 Chemical composition of Vaccinium macrocarpon 
Fresh cranberry fruits (“cranberries”) contain >80% water and 10% carbohydrates 
(glucose and fructose). Other constituents are flavonoids, triterpenoids, organic acids and 
ascorbic acid. The major organic acids are citric, malic, and benzoic acids, as well as 
quinic and glucuronic acids. The high amount of organic acids makes the single-strength 
juice very acidic (pH < 2.5) and unpalatable (Raz et al., 2004). Cranberries are rich sources 
of dietary flavonoids including anthocyanins and proanthocyanidins (Jepson and Craig, 
2007). A total amount of 400 mg of flavonoids and phenolics per liter of a freshly 
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squeezed cranberry juice was reported, distributed as about 44% of phenolic acids and 56% 
of flavonoids (Chen et al., 2001). 
There are eight major classes of flavonoids: flavones, flavonols, flavanones, flavan-3-
ols, anthocyanidins, isoflavones, chalcones and dihydrochalcones. They result from 
variations in the structural arrangement and positions of the functional groups. Possible 
glycosilation at multiple sites with a various saccharides and their further acylation 
produce a group containing more than 5000 chemically distinguishable compounds (Lin 
and Harnly, 2007). The unique flavonoids of cranberry, including anthocyanins, 
proanthocyanins and flavonol glycosides are responsible for the attractive bright 
appearance and distinctive flavor of the cranberry fruit. They are also believed to 
contribute to the health promoting effects of cranberry products. Foo et al. (2000) 
elucidated the structures of the cranberry proanthocyanidins (condensed tannins), which 
inhibit the adherence of uropathogenic Escherichia coli in vitro. Rare A-type low 
molecular weight procyanidins were found in cranberry at higher concentrations than the 
more common B-type procyanidins (Määttä-Riihinen et al., 2005). Fruit phenolics, 
including flavonoid and non-flavonoid compounds, are also of interest in food science, as 
they have impact on the color quality, adstringency and shelf stability of fresh and 
processed fruits (Kalt et al., 2008).  A summary of flavonoids and their glycosides present 
in V. macrocarpon is given in table 1 (Mullen et al. 2007; Lin and Harnly 2007; 
Vvedenskaya et al. 2004). The vast majority of  flavonoids and phenolic acids in cranberry 
juice, up to 85%, occur as esters or bound phenolic compounds (Chen et al., 2001). 
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Tab. 1. Reported flavonoids and their glyocosides in V. macrocarpon  
 
 
R1,2 = OH 
Myricetin-3-β-galactoside 
     Myricetin-3-α-xylopyranoside 
     Myricetin-3-α-arabinofuranoside 
     Dimethoxymyricetin-hexoside 
     Methoxymyricetin-pentoside 
 
  
Quercetin-3-β-galactoside 
 
 
     Quercetin-3-β-glucoside 
     Quercetin-3-β-xylopyranoside 
     Quercetin-3-α-arabinofuranoside 
     Quercetin-3-α-rhamnopyranoside  
     Quercetin-3-O-(6’’-p-coumaroyl)-β- galactoside 
     Methoxyquercetin-pentoside 
     3’-methoxyquercetin-3-α-xylopyranoside  
 
 
 
R1,2 = H 
 
Kaempferol-3-glucoside 
     Methoxykaempferol derivatives 
 
 
 
 
 
R1,2 = OH 
Cyanidin-3-arabinoside 
     Cyanidin-3-galactoside 
     Cyanidin-3-glucoside 
 
 
 
 
 
 
R1 = OCH3 
R2 = H 
      
Peonidin-3-galactoside        
Peonidin-3-glucoside 
Peonidin-3-arabinoside 
 
 
 
 
 
Epicatechin 
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Proanthocyanidin oligomers (n = 1 or 2) Catechin-(4α-2)-phloroglucinol (3) 
 
 
 
 
 
 
Epicatechin-(4β-2)-phloroglucinol (4) 
Epigallocatechin-(4β-2)-phloroglucinol (5) 
 
 
          
 
 
 
Epicatechin-(4β-8, 2β-O-7)-epicatechin 
 
 
 
Epicatechin-(4β-8)-epicatechin-(4β-2)-
phloroglucinol 
 
            
                                         R = H 
     
         
Tab. 2. Structures of bioactive proanthocyanidins in V. macrocarpon (Foo et al., 2000) 
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5. Urinary tract infection 
5.1 Urinary tract infection 
Under normal conditions, urine in the bladder is sterile, and the term urinary-tract 
infection (UTI) refers to the presence of microorganisms in the urinary tract, including the 
bladder, prostate, collecting system, and kidneys (Henig and Leahy, 2001). Most 
uncomplicated UTIs in women seem to result from the interaction of infecting agents with 
uroepithelial cells in the bladder (Hooton, 2001). The vast majority of UTIs is caused by 
bacteria and Escherichia coli (E.coli) is the most common uropathogen, detected in 70 – 
95% of the cases. Other uropathogenic strains are Staphylococcus saprophyticus  (isolated 
in 5 – 20% of cases), Proteus mirabilis, Klebsiella species or Enterococci (Franco, 2005). 
This is the case for community-acquired infections. Most uropathogens originate from the 
rectal flora and follow an ascending way through the urethra into the bladder with an 
interim phase of periurethral and distal urethral colonization (Hooton, 2001). In contrast to 
this, hospital-acquired infections or infections complicated by underlying host factors tend 
to be polymicrobic and multi-drug-resistant (Franco, 2005). Throughout all age groups, 
UTIs are more prevalent among women than among men. It has been estimated that 
approximately 25% of women have had at minimum one UTI in their lifetime and will 
suffer several (Henig and Leahy, 2000). 
 
5.2 Mechanism of infection 
As mentioned in chapter 5.1, healthy urine is sterile and bacterial entry with subsequent 
proliferation in the urinary tract is required for disease to occur. Bacteria located within the 
urinary tract will not cause disease unless they proliferate. The phase of proliferation seems 
to occur through bacterial attachment to the urinary tract mucosal surface cells, followed 
by bacterial multiplication and infection of the host tissue (Henig and Leahy, 2000). 
Therefore, bacterial adherence to uroepithelial cells appears to be the crucial step in the 
pathogenesis of UTIs, especially cystitis (bladder infection) (Howell, 2007; Henig and 
Leahy, 2000). Specific bacterial surface-structures - fimbriae or pili - facilitate bacterial 
binding to host-receptors, located on the cell surface (Raz et al. 2004). An adhesion 
molecule - adhesin - is displayed at the distal end of each such pilus (Franco, 2005).  
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The two most important uropathogenic E. coli adhesins are P fimbriae (papenconded 
adhesins) and type 1 pili. P fimbriae bind to host cells by means of their tip adhesins, 
encoded by PapG, which attach to cell-surface glycosphingolipids of the globoseries 
family. In vitro studies have demonstrated that the attachment of P fimbriated strains to the 
tissue leads to cytokine release and ceramide signalling (Stapleton, 2003). Type 1 fimbriae 
are found nearly universally among uropathogenic and nonpathogenic, e.g. fecal 
commensal, E. coli isolates.  They enable adhesion to uroepithelial cells followed by 
invasion of the bladder. Type 1 fimbriae display the FimH adhesin on their surface, which 
binds mannose (mannose-sensitive fimbriae). In the bladder, mannosylated residues can be 
found across the luminal uroepithelial surface (Franco, 2005).    
Once attached, the uropathogenic bacteria will divide rapidly and form small clusters, 
building up intracellular bacterial communities (IBCs). Due to their intracellular location, 
they are not killed by antibiotic agents. After going through some developmental stages, it 
comes to the formation of bacterial communities, which possess biofilm-like properties. 
Biofilms represent collections of microorganisms, attached to a surface or to each other, 
which display community behaviour and provide protection from environmental changes 
or insult. The formation of biofilms leads to resistance of bacteria to the host defence 
system by protecting the bacteria inside the matrix, and to antibiotic treatment, as the drugs 
are not able to penetrate the biofilm matrix. Single bacteria can detach from the 
intracellular biofilm and rebind to another part of the epithelium to form a new generation 
of IBCs or a reservoir. During the reservoir phase, host and bacteria are quiescent. Despite 
antibiotic treatment, the uropathogen can persist in this state for the duration of months 
following the intial infection (Franco, 2005). 
 
5.3 Recurrent urinary tract infection  (RUTI)  
The term recurrent urinary tract infection (RUTI) refers to a symptomatic UTI that 
follows the state of a previous infection, generally, but not necessarily, after treatment 
(Hooton, 2001). The diagnosis RUTI is made at the occurrence of three or more 
symptomatic episodes over a 12-month period (Franco, 2005). Most recurrences occur 
during the first three months after the intial infection (Hooton, 2001). Recurrent UTIs are 
common and can affect also young, healthy women with anatomically and physiologically 
normal urinary tracts.  
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Occasionally, recurrences occur due to a persistent focus of infection (relapse). The 
initially infecting strain may persist in the fecal flora after elimination from the urinary 
tract, re-colonize the bladder and lead to recurrent UTI. The vaste majority of RUTI 
however, is believed to result from re-infection, which indicates that it is caused by a 
different strain than the original infection (Hooton, 2001). 
It has been shown that women with recurrent UTI are more susceptible to vaginal 
colonization with uropathogens in comparison to women without a history of recurrent 
UTI. The prevalence of vaginal colonization with Escherichia coli, Enterococcus faecalis, 
Proteus mirabilis, and Klebsiella was significantly higher in women suffering from 
recurrent infections. It has been demonstrated, that women with recurrent UTI were subject 
to colonization with gram-negative bacilli, that was heavier and lasted longer, compared 
with controls (Hooton, 2001). 
The development of recurrent UTI in healthy women mostly starts with vaginal 
colonization by enteric flora, especially with uropathogens, such as Escherichia coli. 
Uropathogenic E. coli (UPEC) subsequently passes an interim phase of periurethral and 
distal urethral colonization. This colonization in combination with the presence of an 
anatomically given shorter urethra facilitate bladder colonization and infection. 
Uropathogenic E.coli  strains are able to produce an acidic polysaccharide capsule to 
protect themselves from phagocytosis by human leucocytes and to inhibit complement 
activation (Franco, 2005).  
 
5.4 Diagnosis of UTI 
The “gold standard” bacteriological criteria for diagnosis of UTI include 
microbiological confirmation by urine culture from a midstream specimen of urine (MSU). 
For young, symptomatic women the diagnostic criterion should be 100 CFU/mL (Franco, 
2005), which is often associated with pyuria (white cells in the urine) (Jepson and Craig, 
2007). Classic symptoms of cystitis (bladder infection) include dysuria (pain on passing 
urine), frequent and urgent need to urinate, cloudy urine and suprapubic discomfort. Upper 
tract involvement leads to loin pain, haemuria (blood in the urine) and fever. In the elderly, 
these symptoms may result in a general feeling of being unwell and confusion (Franco, 
2005; Henig and Leahy, 2000). 
Cystitis only very rarely progresses to pyelonephritis, although the bladder is usually 
also affected during a kidney infection. Host and bacterial factors play a role in kidney 
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involvement: pregnancy increases the risk of movement of bacteria into the kidney, and 
bacteria with  special characteristics cause pyelonephritis (Foxman and Brown, 2003). 
 
5.5 Risk factors 
Generally, all humans are susceptible to UTI. However, certain circumstances increase 
the exposure to potential uropathogens and others increase the susceptibility to the 
development of UTI symptoms following bacterial colonization. Important markers of host 
susceptibility to (recurrent) UTI include age, gender, pregnancy, diabetes and prostatic 
enlargement (Foxman and Brown, 2003). Throughout all age groups, women have a 
significantly higher incidence of UTI than men. This fact can be partly explained by 
differences in anatomy: women have moister periurethral spaces and shorter distances 
between the anus and urethral opening and between the urethral opening and the bladder. 
Most UTIs result from an ascending way of infection (Foxman and Brown, 2003). These 
factors increase exposure to potential uropathogens and increase their ability to colonize 
the urinary tract. Table 3 sums up the UTI risk factors for different pupulation segments. 
 
Risk factors for urinary tract infection (UTI) 
young premenopausal women sexual intercourse 
 contraception (diaphragm, spermicide) 
 pregnancy 
 anatomy (distance urethra – anus) 
 non-secretor status 
 genetics 
 antimicrobial use 
 history of recurrent UTI 
elderly postmenopausal women urogenital atrophy (postmenopausal estrogen deficiency) 
 diabetes mellitus 2 
 high post-void residual 
 incontinence 
 presence of cystocoele 
 urogenital surgery 
 non-secretor status 
 history of recurrent UTI 
hospitalized patients indwelling catheter 
 ureteric stent 
 nephrostomy tube 
 obstruction (e.g. urolithiasis) 
 malignancy 
 renal cyst 
 neurogenic bladder 
 urethral diverticulum 
Tab. 3. Summary of risk factors in different population segments 
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Young premenopausal women 
In the population of young premenopausal women, sexual intercourse, diaphragm-
spermicide use, and a history of recurrent UTI have been demonstrated to be strong and 
independent risk factors. Suffering the first infection at an early age and having a mother 
with a history of UTIs were associated with a two – four-fold increased risk of UTI 
(Hooton, 2001). Bladder trauma, associated with sexual activity, and potentially increased 
by (spermicide-coated) condom use, offers uropathogens the opportunity to enter and 
interact with the bladder walls. Contraception strategies such as diaphragms, (spermicide-
coated) condoms, and spermicides are all correlated with an increased risk of UTI. (Miller 
and Krieger, 2002) Spermicides, e.g. Nonoxynol 9, increase the risk of UTI by altering the 
vaginal ecosystem in favor of uropathogens through harming the physiological lactobacilli, 
while having little or no direct effect on uropathogenic E.coli (Franco, 2005). In this way, 
spermicides reduce the vaginal lactobacilli population, facilitating colonization of vagina 
with E. coli (Miller and Krieger, 2002). 
UTIs often occur during pregnancy. The majority of  UTIs during the time of pregnancy 
pass asymptomatically, but they bear the risk of leading to a low-birth-weight infant or 
preterm birth.. Pyelonephritis can also cause severe maternal and fetal morbidity and 
mortality (Henig and Leahy, 2000). Pregnancy and anatomic abnormalities increase the 
ability of uropathogens to ascend to the bladder and kidney. Data indicate that anatomic 
differences may have an influence on predisposing young women to recurrent UTI, 
especially when other exogenous risk factors for UTI are absent (Hooton, 2001). 
It is believed that an increased susceptibility to UTI can also result from genetic 
determination. Women with recurrent UTI were shown to be three – four times more likely  
non-secretors of ABO histo-blood group antigens. Uropathogenic E.coli (UPEC) adheres 
better to uroepithelial cells from women who are non-secretors. The biochemical 
explanation for the increased adherence of E. coli to these cells seems to be the presence of 
unique globoseries glycolipid receptors (sialosyl galactosylgloboside and disialosyl 
galactosylgloboside), which are exclusively found on epithelial cells of non-secretors. 
These receptors can bind uropathogenic E. coli more effectively than other globoseries 
glycosphingolipids present in the vaginal epithelial cells (Franco, 2005; Stapleton, 2003). 
Another factor with genetic variability and possible influence on the development of 
UTI is the interleukin-8-receptor CXCR1. IL-8 is an inflammatory cytokine which causes 
neutrophil migration across infected uroepithelial cells. Studies have shown that knockout 
mice without CXCR1 were not able to clear bacteria from the kidney, ultimately leading to 
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bacteremia. Analysis of the CXCR1 expression in neutrophils of children with a history  of 
recurrent pyelonephritis has detected a defective version of the IL-8 receptor, which might 
explain their increased susceptibility to recurrent pyelonephritis (Hooton, 2001). 
Voiding and drinking habits do not seem to play a role in the development of UTIs 
(Miller and Krieger, 2002). 
 
Elderly postmenopausal women  
After menopause, the reduced estrogenic levels seem to contribute to the more frequent 
occurence of UTI in healthy postmenopausal women. It has been shown that topically 
applied intravaginal estrogen lead to normalization of the vaginal flora and significantly 
decreased the incidence of recurrent UTI (Hooton, 2001). Diabetes, mostly affecting the 
elderly, is a risk factor for asymptomatic bacteriuria. Among postmenopausal women, 
diabetes leads to a twofold increase of acute UTI. Patients suffering from diabetes may 
also have a weaker host response, hence, their uroepithelial cells may be more susceptible 
to bacterial binding (Foxman and Brown, 2003). 
 
Hospitalized patients 
The likelihood of bacteriuria increases with the patient´s advancing age and is highest 
among elderly institutionalized women. The presence and prolonged use of an urogenital 
medical device, such as catheter or urethral stent enhances the risk and severity of UTI 
significantly (Henig and Leahy, 2000). Obstruction of urinary flow, e.g. due to prostate 
enlargement in men, and residual urine in the bladder, e.g. due to spinal cord injury, 
decreased bladder tone or neuropathy, increase the risk of bacteriuria. Incrased residual 
bladder volume enables the maintenance of bacterial colonization, which provides the 
uropathogen additional opportunities to interact with the host epithelial cells (Foxman and 
Brown, 2003). Complicated UTIs are more likely to origin from infections with muli-
resistant pathogens. Factors causing urinary stasis, such as urolithiasis, malignacy, renal 
cyst and neurogenic bladder increase the UTI risk. The main UTI risk factors in 
hospitalized patients include an indwelling catheter, ureteric stent, or nephrostomy tube. 
Also, some diseases or medical conditions, e.g. diabetes mellitus, renal failure, renal 
transplantation, and immunosuppression, can cause a higher susceptibility to uropathogens 
by bypassing normal host defences (Franco, 2005). 
 
  27
5.6 Management/Treatment 
Before medication is prescribed, reversible risk factors should be considered, and as far 
as possible, corrected. Women using spermicides or diaphragm, might consider alternative 
strategies of contraception. For hospitalized patients with catheters, catheter management 
should be reviewed. In the elderly, perineal hygiene, hydration, and bladder or bowel 
incontinence are important factors to be managed. Postmenopausal women suffering from 
recurrent UTI might consider estrogen therapy (Franco, 2005) 
The standard treatment for  an acute urinary tract infection is antibiotic therapy (Howell, 
2007; Reid, 1999; Franco, 2005). Trimethoprim-sulfamethoxazole (TMP-SMX) in a three-
day regimen is considered the treatment of first choice for acute and uncomplicated 
bladder infections. Three-day course regimens are generally prefered, due to their better 
compliance, lower cost, and lower frequency of adverse reactions compared to the seven – 
ten day administration (Hooton, 2001). Nitrofurantoin is a safe and effective drug for the 
treatment of uncomplicated UTIs, but it should be administered for at least seven days. The 
use of fluoroquinolones is a  reasonable alternative for women who are known or suspected 
of having resistant organisms or who are allergic to more conventional treatments. 
Fluoroquinolones are also prescribed in areas with high resistance to trimethoprim-
sulfamethoxazole ( >15 – 20%). Risk factors for the development of a TMP-SMX 
resistance include diabetes, recent hospitalization, recent antibiotic use and recent TMP-
SMX use (Hooton, 2001). 
 
5.7 Prevention 
Prophylactic treatment is relevant for women who experience two or more symptomatic 
UTIs over a 6-month period, or three or more over a 12-month period (Hooton, 2001). 
Each infection causes two – three days of symptomatic illness and chronic UTI can lead to 
long-lasting pain and discomfort. An acute UTI causes the loss of several working days 
and requires about one week for recovery. Hence, patients are eager to prevent a recurrence 
and a motive for prevention exists. Current key strategies in UTI prevention are: antibiotic 
prophylaxis, cranberry products, lactobacillus-based probiotic preparations, and vaccine 
development (Stapleton, 2003). 
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5.7.1 Antibiotic prophylaxis 
In the situation where the infection cycle has no known cause, the use of antibiotics 
represents the method used most to manage recurrent UTIs. This approach represents 
treatment of the patient with antibiotics in amounts that prevent bacterial multiplication 
and infection of the bladder (Reid, 1999). 
 
a) long-term prophylaxis 
Following antimicrobials can be used in long-term prophylaxis: trimethoprim/ 
sulfamethoxazole (TMP-SMX) (40/200 mg), trimethoprim (TMP), nitrofurantoin (50 mg) 
or norfloxacin (200 mg). In the long-term preventive treatment, antibiotics are 
administered for six – twelve months. In some cases this period can be extended to two – 
five years. The medication can be given on alternate nights or 3 nights a week (Franco, 
2005; Reid, 1999). This approach effectively prevents recurrent infections in 95% of 
patients during antibiotic intake. However, it has been shown, that 50% of the patients will 
suffer an infection within only three months after prophylaxis has been finished (Franco, 
2005). The effect of prophylactic long-term antibiotic intake therefore seems to be only 
short-lasting.  
 
b) post-coital therapy 
Post-intercourse prophylaxis is an option for women, who have defined sexual 
intercourse as their main UTI risk factor. Post-coital therapy  consists of the intake of a low 
dose of antibiotics immediately after voiding post-intercourse. Studies compared this 
approach with daily antibiotics intake for UTI prevention. Post-coital prophylaxis was 
found to be more effective than placebo and as effective as daily antibiotics intake (Franco, 
2005). 
 
c) patient initiated therapy 
Patient-initiated therapy is an ideal UTI prevention method for women who are not 
suitable or not willing to take long-term daily prophylaxis. Women can initiate therapy at 
the onset of their known symptoms, starting antibiotics intake empirically and continuing 
the intake for three days (Franco, 2005). 
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Side effects of antimicrobial therapy:  
Normal vaginal flora comprises lactobacilli and staphylococci which provide effective 
protection from infection caused by uropathogens. Some antimicrobials agents have 
adverse effects on the vaginal ecology. Perturbation of the normal flora leads to reduced 
adherence of lactobacilli to vaginal epithelial cells in vivo, enabling persistent colonization 
by Escherichia coli. It has been demonstrated that vaginal fluid of women suffering from  
recurrent UTI binds E.coli more effectively. β-lactam antibiotics cause significant changes 
in the physiological vaginal flora followed by  increased genital uropathogen colonization. 
Studies have demonstrated that TMP and nitrofurantoin have less negative effects on the 
vaginal flora compared to amoxycillin (Franco, 2005). 
The contribution of continual low-dose antibiotic regimens for UTI prevention to 
increasing bacterial resistance, represents a major problem. Additionally to the patient´s 
wish to prevent UTI, the increasing number of E.coli isolates resistant to antimicrobial 
agents has stimulated interest in novel, nonantibiotic approaches for the prevention of 
infections. Antibiotics intake causes increased presence of drug-resistant microorganisms 
in the rectum, perineum, and urethra. Depending on the antibiotic agent in use, many 
patients suffer from yeast vaginitis following antibiotics treatment, as a result of disruption 
of the physiological flora. Trends in health care and society show a movement toward the 
preferred use of natural remedies instead of chemotherapeutic regimens (Reid, 1999). 
 
5.7.2 Role of cranberry in prevention of (R)UTI 
 
Mode of action: anti-adherence activity 
Cranberry (Vaccinium macrocapron Ait.) ingestion, particularly in the form of 
cranberry juice, has long been associated with prevention of urinary tract infections 
(Howell, 2007; Jepson and Craig, 2007; Reid, 1999). The beneficial mechanism was 
historically thought to be due to the fruit acids causing a bacteriostatic effect in the urine. 
However, it has been shown that  cranberry juice, in contrast to earlier thinking, apparently 
does not significantly alter the urinary pH (Lowe and Fagelman, 2001; Hooton, 2001; 
Stapleton, 2003). Ingestion of large amounts of cranberry juice would be required to only 
slightly reduce urinary pH and increase the concentration hippuric acid. Therefore, the UTI 
preventive effect of cranberry has to be ascribed to a different mechanism of action (Raz et 
al., 2004). 
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In vitro and ex vivo studies demonstrate anti-adherence effect of cranberry products to 
uropathogenic bacteria (Bailey et al., 2007). Specific proanthocyanidins (PACs), 
condensed tannins with A-type linkages, were isolated from cranberry, which exert 
antiadhesion activity against antibiotic susceptible and resistant strains of uropathogenic P-
fimbriated E. coli (Howell, 2007). As described in chapter 5.2, infection is initiated by 
bacterial adherence to epithelial cells, followed by bacterial multiplication and colonization 
of the urinary tract. Therefore, the adherence of uropathogens to uroepithelial cells can be 
seen as the crucial step in the pathogenesis of UTIs. Virulence factors in respect to the 
pathogenesis of UTI represent adhesins, which are displayed on the bacterial surface and 
facilitate the adherence to carbohydrate receptors on the surface of uroepithelial cells. The 
vast majority of uropathogenic E. coli strains expresses type 1 fimbriae that bind mannose-
like receptors. P-fimbriated (mannose- resistant) E. coli adhere to oligosaccharide 
sequences [α-Gal(1 → 4)β-Gal] of receptors located on the uroepithelial surface and are 
therefore correlated with cystits and pyelonephritis (Howell, 2007).  
Zafriri et al. (1989) identified two bioactive compounds in cranberry that exert 
inhibitory effect on E.coli adhesins. The monosaccharide fructose inhibits adhesion of 
mannose-sensitive fimbrial type 1 adhesins to uroepithelial cells, which has only been 
demonstrated in vitro. The other, proanthocyanidins (PACs), inhibits mannose-resistant (P-
fimbriated) adhesins of uropathogenic E. coli strains. Bioavailability studies suggest that 
these compounds are absorbed after intake. 
Although all fruit juices contain fructose, only juices from Vaccinium berries 
(cranberries and blueberries) contain proanthocyanidins, the mannose-resistant adhesin 
inhibitors (Henig and Leahy, 2000; Raz et al., 2004). 
PACs are tannins, polyphenolic compounds, which are a part of the plant defence 
system responding to environmental stress and microbial infection (secondary 
metabolites). The adstringency of PACs serves the young berries as protection against 
animal and insect predators and is responsible for the unique adstringent taste of cranberry 
juice.  
A special characteristic of PACs is their ability to bind proteins, suggesting one possible 
mechanism of antiadherent action. PACs, acting as receptor analogues can competitively 
inhibit adhesion of E. coli to uroepithelial surface by binding their fimbrial tips (Howell, 
2007). The group of PACs isolated from cranberry comprises generally epicatechin units 
with at minimum one A-type linkage. The molecular structures of the bioactive A-linked 
PACs were determinded by Foo et al. (2000) and found to be active in the antiadhesion 
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assays (Howell, 2007). Studies have demonstrated that proanthocyanidins containing A-
type linkage were more effective regarding their antiadherent activity compared to PACs 
containing only B-type linkages. Therefore it can be concluded, that A-linkage in cranberry 
proanthocyanidins, which can occur at the terminal unit or between the extension units of 
the PAC molecule, appears to represent an essential structural characteristic for bacterial 
antiadhesion activity. Heterogeneous structures of cranberry PACs may arise during fruit 
ripening or resul from post harvest processing. (Howell, 2007). 
Representing a different mode of action, cranberry compounds may also lead to changes 
of P-fimbriated uropathogenic E. coli in various ways, resulting in decreased adhesion 
capabilities. Cranberry PACs may for example influence adhesion by altering cell surface 
properties of the bacteria resulting in a shift of the zeta potential distribution (electrical 
potential across the interface of solids and liquids) in the positive direction. pH-neutralized 
cranberry juice was also shown to cause conformational changes in surface 
macromolecules of P-fimbriated E. coli, leading to decreased fimbrial length and density. 
Cranberry PACs may also induce a change in the bacterial shape from rods to spheres. 
Data also suggest that cranberry compounds may reduce fimbrial expression at the genetic 
level (Howell, 2007; Bailey et al., 2007). Bacteria incubated in cranberry-containing media 
demonstrated a 95% reduction in their fimbrial expression and showed extreme cellular 
elongation (Henig and Leahy, 2000). 
 
Cranberry juice cocktail 
The most common form of cranberry consumption is cranberry juice cocktail (CJC), a 
sweetened beverage comprising approximately 25% single-strength cranberry juice, 
sweetener, water and vitamine C (ascorbic acid). The single-strength juice is highly acidic, 
pH ~2.5, and quite adstringent. These properties make the fruit juice quite unpalatable at 
full strength.  
 
Side effects and compliance 
Generally, the safety of cranberries and derived products is considered to be excellent. 
Some patients though, may experience a mild laxative effect, when larger amounts are 
ingested. In high-risk patients, however, the regular ingestion of  large amounts of 
cranberry products over a long period may increase the risk of urinary stones, due to the 
increased urinary excretion of oxalate and slight urinary acidification (Raz et al., 2004). 
Other reported side effects include reflux, mild nausea and frequency of bowel movements. 
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In some of the trials the number of withdrawals was very high (20 – 47%), indicating that 
cranberry juice cocktail does not represent an acceptable therapy when taken over a long 
duration (Jepson and Craig, 2007). Also the unique taste, main withdrawal reason for 
children, and caloric load of cranberry juice cocktail decrease the acceptance of many 
patients. Capsules of cranberry concentrate could represent an alternative. Ultimately, the 
cost of consuming larger amounts of cranberry juice may represent a limiting factor in 
general acceptance. Cranberry products are currently not covered by health insurance 
(Jepson and Craig, 2007; Raz et al., 2004).  
 
Clinical studies/Evidence 
In recent years, cranberry consumption has been more and more recommended as a safe 
alternative for UTI prevention. There seems to be positive evidence that cranberry juice 
consumption can decrease the number of symptomatic UTIs. 
In vitro studies detected a strong antiadherence activity when uropathogenic bacteria 
were preincubated with cranberry juice (Henig and Leahy, 2000). Preincubation of 
uropathogenic E.coli strains in fresh cranberry juice for only 30 seconds was shown to 
result in inhibitory activity. After 24 and 48 hours, the number of E. coli colonies was 
reduced to approximately 50% (Lowe and Fagelman, 2001). In vivo studies have 
demonstrated that urine from mice and humans, collected after drinking cranberry juice 
containing PAC with A-type linkages, exerted significant inhibitory effects on bacterial 
adherence compared to control urine (Howell, 2007; Henig and Leahy, 2000; Stapleton, 
2003).  
Additionally to antiadherence effects, in vitro studies have reported decreased fimbrial 
production of E. coli grown on agar medium containing cranberry juice. This was in 
correlation with fimbrial functional assays. Cranberry juice in liquid growth medium has 
also shown antimicrobial activity against a broad spectrum of uropathogenic bacteria 
(Stapleton, 2003).  
Cranberry juice was added to a culture epithelial cells with adherent E. coli to study its 
antiadherent effect, when bacteria were already attached to receptors on the cell surface. 
An occasional and variable release response was observed. The variable efficacy of 
cranberry juice in releasing already adhered uropathogens limits its potential as a treatment 
strategy for an acute infection (Lowe and Fagelman, 2001). In contrast to UTI prevention, 
where cranberry is believed to be effective at least in certain population segments, there is 
currently no evidence that cranberry can treat UTI once an infection is present. 
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The evidence for cranberry and derived products indicates that it can be effective in 
reducing recurrent UTIs in certain subpopulations. The strongest evidence available is for 
sexually active women with a history of recurrent UTI (Raz et al., 2004). The evidence is 
more inconclusive regarding its effectiveness in elderly men and women, although one trial 
demonstrated a decreased incidence of bacteriuria and pyuria in this high-risk population 
after regular consumption of 300 ml of cranberry juice cocktail (Lowe and Fagelman, 
2001). There is currently no evidence that cranberry juice consumption for the purpose of 
preventing recurrent UTIs is effective in patients with neuropathic bladder (Jepson and 
Craig, 2007). Also, cranberry consumption did not alter the frequency of UTIs or 
bacteriuria in the population segment of patients with intermittent catheterization. The lack 
of benefit in this population may be explained by a low volume of cranberry concentrate 
ingested or the patients´ inherent dysfunction, which might have overridden any clinical 
effect of cranberries in this case (Lowe and Fagelman, 2001; Raz et al., 2004).  
A cranberry preparation with a standardized phenolic content of 30% (25% minimum 
proanthocyanidins) was reported to be successful in the prevention of UTIs in women who 
were subject to recurrent infections. The standardized cranberry preparation was 
administered twice daily (one capsule) for twelve weeks, each capsule contained 200 mg 
standardized cranberry extract. The preparation used was much higher in phenolic content 
than both dried cranberries with 0.5% and dried juices with 3% to 7%. None of the women 
developed a UTI in the course of the study, neither on the basis of symptoms nor 
laboratory results, which was in contrast to their UTI history of an infection every two 
months. Women who continued the intake of the phenolic-rich cranberry product remained 
free from infections during the following two years. These results suggest a possible 
correlation between the amount of phenolic compounds ingested and the UTI preventive 
effect. Results of this preliminary study indicate that women with a history of recurrent 
UTIs can prevent these recurrent infections by daily intake of a cranberry extract. 
However, further studies are required, including a control group. (Bailey et al., 2007). 
Summarizing, there seems to be evidence that cranberry and derived products are 
effective agents for the prevention of UTIs, particularly in women suffering from recurrent 
infections and the elderly, but not in patients with abnormal bladder function requiring 
catheterization, regardless their age. However, none of the trials justified the dosage of the 
administered cranberry product. Additionally, the chemical composition varies between 
different cranberry products. There is no standardization, and the bioequivalence between 
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cranberry juice and other formulations, such as capsules/tablets is not clear (Jepson and 
Craig, 2007). Future trials should be conducted with cranberry products comprising 
known, characterized, and quantified ingredients. A standard analytical method for 
cranberry products combining accurate PAC quantification with antiadhesion bioactivity 
analysis would enable manufacturers to formulate efficacious cranberry products (Howell, 
2007). 
Currently, there is no evidence regarding the amount and concentration as well as 
duration of cranberry intake to be most effective. It has been postulated that future trials 
may need to cover a longer time period, so that the natural course of the illness is taken 
into account. Current knowledge suggests a glass of cranberry juice twice a day (daily 
dosage: 240 – 300 ml) (Jepson and Craig, 2007, Howell, 2007). 
It is believed that proanthocyanidins with A-linkage are the main bioactive ingredients 
in cranberry products, but only little is known about their metabolism (Stapleton, 2003). 
No data are available, which compare cranberry products with established strategies, such 
as antibiotics for UTI prevention. Theoretically, the use of cranberry products instead of 
antibiotics to prevent UTIs might lead to a decreased number of antibiotics-resistant 
organisms, but there is currently no evidence supporting this theory (Jepson and Craig, 
2007).  
 
5.7.3 Probiotics 
defences against UTI: the normal vaginal flora 
The physiological vaginal flora of estrogenized, premenopausal, nonpregnant women, 
represents a complex microbial ecosystem comprising 108 to 109 cfu/ml of vaginal fluid, 
containing over 50 bacterial species. 90% of these bacteria are lactobacilli with L. 
crispatus being the most common species found in the vaginal flora of healthy 
premenopausal women. This benign vaginal flora prevents colonization by virulent, 
uropathogenic microorganisms. (Stapleton, 2003) 
Lactobacilli protect the vagina from colonization by uropathogens through various 
modes of action, including steric hindrance or blocking potential sites of attachment, 
competition for nutrients, production of hydrogen peroxide and maintenance of a low pH 
(Hooton, 2001; Miller and Krieger, 2002). The reduction or complete loss of lactobacilli, 
particularly the H2O2-producing species L. crispatus or L. jenseii, e.g. following antibiotic 
treatment or use of spermicides, is correlated with an increased risk of colonization with 
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uropathogenic E. coli strains. Conditions causing perturbations of the normal vaginal 
ecology are associated with increased risk of UTI (Stapleton, 2003).  
Probiotics can be defined as biotherapeutic agents comprising living microorganisms, 
which are administered to promote the host´s health by treating or preventing infections 
owing to strains of pathogens (Reid, 1999). Lactobacillus probiotic therapy supports the 
restoration of the normal vaginal flora, which might be disturbed by antimicrobial agents, a 
common problem following antibiotic therapy for UTI. The number of lactobacilli 
required for the maintenance of vaginal flora capable to resist uropathogens has not been 
defined (Reid, 1999). However, many lactobacilli present in dairy products do not seem 
suitable for UTI prevention in humans (Miller and Krieger, 2002). 
 
5.7.4 Estrogen 
In healthy postmenopausal women, the reduced levels of estrogenic hormones occuring 
after menopause seem to contribute to an increased incidence of recurrent UTI. Topically 
applied intravaginal estrogen has been shown to normalize the vaginal flora and 
significantly reduce the occurrence of recurrent UTI (Miller and Krieger, 2002; Hooton, 
2001). Therefore, estrogen seems to play a role in the maintenance of the normal vaginal 
flora and to reduce the risk of UTI. However, increased estrogen amounts may enhance the 
risk of UTI by facilitating adherence of uropathogens to uroepithelial cells. Local estrogen 
therapy is considered to lack the adverse effects of systemic estrogen intake (Franco, 
2005). 
 
5.7.5 Others 
In addition to long-term administered antibiotics, methamine hippurate 1 g (twice daily) 
and povidone-iodine urogenital washes (twice daily) have been employed for long-term 
UTI prevention, but patient compliance and efficacy have not been satisfactory enough to 
make these the treatments of choice (Reid, 1999). For patients with renal insufficiency, 
cephalexin 125 mg can be prescribed (Franco, 2005). 
 Deliberate bacterial colonization of the bladder has been reported to significantly 
decrease the incidence of recurrent UTIs among patients with spinal cord injury. In this 
approach, a relatively benign isolate of E. coli is used to colonize the patient´s bladder in 
order to competitively inhibit the formation of colonies by more pathogenic strains. This 
concept of deliberate colonization finds appeal in a patient population where urinary tract 
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colonization with some organism, generally an uropathogen, is inevitable (Stapleton, 
2003).  
Mono- or oligosaccharides containing carbohydrates cleaved from native 
glycosphingolipids were reported to have inhibitory effects on bacterial colonization on 
UTI mouse models. These compounds do not cause bacterial resistance to antibiotics and 
can be synthesized in nonhydrolyzable forms (Stapleton, 2003). 
Ultimately, two peptides, FALL-39 and cecropin P1 were reported to be active against 
uropathogens but not against lactobacillus strains (Reid, 1999). 
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6. Nuclear magnetic resonance (NMR) spectrometry 
 
6.1 Basic theory of NMR∗ 
NMR technology is based on the fact that in a magnetic field certain nuclei can absorb 
energy in form of electromagnetic radiation in the radio frequency (rf) region at 
frequencies dependent on the characteristics of the sample. An NMR spectrum represents a 
plot of absorption peaks versus peak intensities. 
All nuclei carry a charge, which in some nuclei spins on the nuclear axis, generating a 
magnetic dipole along this axis. Its spin number I describes the angular momentum of the 
spinning charge and can have values of 0, 1/2, 1, 3/2, etc. I = 0 indicates no spin, therefore 
no magnetic properties. Hence, these nuclei, e.g. 12C, 16O cannot be observed in NMR 
experiments. Relevant nuclei for NMR spectrometry are 1H, 3H, 13C, 15N and 31P. They are 
characterized by a spin number of I = ½. The most important nuclei for NMR experiments 
are 1H and 13C. The spin states of nuclei are quantified by the magnetic quantum number 
m. 
 
 
 
    Fig. 3. transition of nuclei to higher energy levels 
     (adapted from Silverstein et al., 2005) 
 
Two energy levels can be taken by I = 1/2 nuclei in a constant external magnetic field 
B0: m = +1/2 representing orientation against the magnetic field and higher energy level, or 
m = -1/2, with the nucleus orientated in the direction of B0 in the lower energy level, 
respectively. The energy levels in a magnetic field are splitted according to the type of 
nucleus (1H, 13C, ...) and B0  with the difference between the two energy levels being 
directly proportional to the magnetic field applied. 1H has a higher frequency than 13C at 
                                                 
∗ summary from Silverstein et al., Spectrometric identification of organic compounds (pp 127 – 175) 
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the same field strength. Hence, the nuclei will be observed at different, well separated 
frequencies and only one nucleus can be detected at one time. After the two energy levels 
for the nucleus have been established, energy in form of rf radiation (v1) is introduced to 
disturb the system causing a transition between the two energy levels. The introduced 
radiofrequency energy is given in megahertz (MHz) and the frequency of 100 MHz at a 
magnetic field strength of 2.35 tesla (T) is required to change the orientation of the 1H 
nucleus. At this ratio, the system is in resonance. The proton absorbes energy, which 
causes its rise to the higher energy level. A spectrum can be obtained by observing the 
nuclei returning to equlibrium state.  
Generally, there are two approaches of introducing energy to the system. Either the 
radiofrequency energy is introduced by continuous-wave (CW) scanning of the frequency 
range or by pulsing the whole range of frequencies with one single burst of radiofrequency 
energy (pulsed FT NMR) to excite all nuclei simulaneously. Nowadays, the initial CW 
spectrometers are mostly replaced by the more powerful FT instruments. 
The pulsed spectrometer introduces radiofrequency energy in form of a pulse with a 
sufficiently large frequency to the sample, which is placed in a constant magnetic field. 
This high power pulse simultaneously excites all sensitive nuclei in the measured sample. 
During the return of the excited protons to equilibrium state they radiate the absorbed 
energy, which is collected by a detector resulting in a free induction decay (FID), a signal 
containing all emitted frequencies over time. The FID is a function of time and can be 
converted into a conventional NMR spectrum, which is a function of frequency, using a 
computer algorithm (Fourier transform, FT). A basic NMR experiment consists of three 
phases: a relaxation delay (tr), which allows the spins to reach equilibrium state is followed 
by a short rf pulse (tp), lifting the nuclei to the higher energy state. During the subsequent 
acquisition (tacq) time, the FID is recorded. Since relaxation times for protons are usually 
on the order of a few seconds or fractions of a second, rapid repetitive pulsing with signal 
accumulation is possible. 
The resulting NMR spectrum is depicted as a series of peaks whose areas are 
proportional to the number of protons they represent. Therefore, NMR can be used as a 
quantitative technique, when the peak areas are measured by an electronic integrator. 
Additionally, a good baseline and resolution are required for accurate integration.  
Instruments which are in general wide use are operating at 300 – 600 MHz. 
Spectrometers above 100 MHz contain helium-cooled superconducting magnets 
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(solenoids) and use the pulsed FT mode. Basic requirements for NMR experiments include 
a generally high field, good field stability and homogeneity and a computer interface. 
The exact radiation frequency absorbed by a nucleus (“chemical shift”) depends on the 
observed nuclear isotope (1H, 13C, etc.) and variations in its local magnetic field. A nucleus 
in a molecule is shielded by its electron cloud, the density of which depends on its 
chemical environment, such as binding partners, bond lengths, etc. The symbol σ 
represents the “shielding constant”, which gives information on the degree of shielding by 
the electron cloud. This depends on the density of the circulating electrons, which is well 
described by the inductive effect exerted by groups attached to the carbon atom. Variations 
of shielding effects within a molecule give rise to different chemical shifts in the recorded 
spectrum. The discrimination of individual absorptions defines the term of high-resolution 
NMR spectrometry.  
The positions of chemical shifts are measured in frequency units from a reference peak. 
The Hz and δ scales depict increased applied frequency on the left and decreased applied 
frequency on the right side from the TMS signal (internal standard, 0 ppm). The chemical 
shifts are given in dimensionless units labeled δ or ppm. They are not dependent on the 
frequency of the employed instrument.  
 
 
Fig. 4. Functional groups absorb energy at characteristic frequencies (Schripsema, 2008) 
 
The form of the signal is strongly influenced by spin-spin coupling. Scalar coupling is 
mediated through chemical bonds and usually not important beyond three bonds. The 
chemical shifts of two coupling protons can be quite widely separated resulting from 
differences in their chemical environment. However, the spin of each proton is slightly 
affected by the other proton, so that each absorption peak will appear as a doublet. The 
frequency difference (Hz) between the two peaks of a doublet is proportional to the 
strength of the coupling and is represented by the coupling constant J. Coupling constants 
are independent of the applied magnetic field between protons and rarely exceed 20 Hz. 
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If the chemical shift difference betwenn protons (∆v) is much larger than the coupling 
constant (∆v/J > 8), two doublets can be observed. As ∆v/J decreases, the doublets will 
approach each other, resulting in a “roofing” effect: the inner two peaks increase in 
intensity, while the outer two peaks decrease, until they result in one single line.  
One neighboring proton induces the formation of a doublet, while two equally coupled 
neighboring protons will give rise to a triplet. The multiplicity is n + 1 (n = number of 
neighboring, equally coupled protons), which is visualized in the Pascal´s triangle. More J 
coupling induces more complex signals.  
The sensitivity of NMR measurements is described in the signal to noise ratio (S / N), 
which is influenced by the gyromagnetic ratio (γ), magnetic field (B0), acquisition time (t) 
and the number of nuclei (n). Noise in NMR measurements is mainly caused by thermal 
noise in the probe and first-stage receiver electronics. The development of cryogenically 
cooled probes led to significant improvements of NMR sensitivity, resulting in decreased 
sample amount requirements. These probes possess cryogenically cooled rf coils (~20°K) 
and show S/N improvement of ~4 x standard probes. 
The sensitivity for 1H nuclei is way higher in comparison to 13C NMR, as almost all H 
in nature represent 1H, in contrast to the low natural abundance of 13C (~1%). Hence, only 
as little as ~1% of the carbons can be observed in a 13C NMR experiment and higher 
amounts of the sample are required. 
A routine 1H NMR sample measured on a 300 MHz spectrometer requires 
approximately 10 mg of the compound in about 0.5 ml solvent in a 5-mm o.d. NMR glass 
tube. Also, microprobes with 1.0 mm, 2.5 mm, or 3 mm o.d. tube are available to reach 
higher sensitivity.  
An ideal NMR solvent should comprise no protons, be inert, low boiling and 
inexpensive. Deuterated solvents are used in modern spectrometers, as these need a 
deuterium signal in order to lock or stabilize the magnetic field. A deuterium “channel” is 
responsible for a constant monitoring and adjustment (“locking”) of the magnetic field to 
the frequency of the deuterated solvent. The deuterated signal is also used to “shim” the 
field. Modern instruments have about 20 – 30 small electromagnets, called shims, which 
are used to assure that the homogeneity of the magnetic field is precise at the center of the 
sample. These shims are computer controlled and can be adjusted in an automated manner. 
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Summarized information obtained from a one dimensional 1H-NMR spectrum: 
- position of the signals ...................... chemical shift 
- form of the signals ........................... coupling constants 
- intensity of the signals ..................... number of nuclei  
 
6.2 Two-dimensional NMR 
The chemical shift range of a 1H NMR spectrum is quite limited and hardly extends 
beyond 10 ppm. Hence, the 1H spectra of multinuclear experiments, e.g. mixtures, crude 
plant extracts etc. are inevitably crowded as there is a large number of contributing 
compounds, most of them giving multiple signals (Colquhoun, 2007; Eisenreich and 
Bacher, 2007). Compared with 1H, the chemical shift range for 13C is about 20 times 
larger. Two-dimensional NMR-experiments allow a spreading of the overlapping signals 
by introducing additional frequency/chemical shift domains. In a standard one-dimensional 
NMR experiment a single broadband rf pulse is introduced, followed by free induction 
decay, whereas a minimum of two consecutive broadband pulses is required for the 
acquisition of two-dimensional spectra (Eisenreich and Bacher, 2007). 
Homonuclear correlation experiments produce spectra with identical frequency axes 
corresponding to the observed nuclei, in most cases 1H. The acquired 1H - 1H COSY 
(Correlation spectrometry) spectra unravel information about 1H - 1H coupling within a 
molecule. This information is useful in the elucidation of carbohydrates, organic and amino 
acids. Heteronuclear correlation experiments generate spectra with two different frequency 
axes, one corresponding to 1H and the other to a different I = 1/2 nucleus, most commonly 
13C (Ratcliffe and Shachar-Hill, 2005).  
Heteronuclear single quantum coherence (HSQC) and heteronuclear multiple bond 
coherence (HMBC) spectra contain information about 1H - 13C coupling (correlation) 
between directly attached nuclei, or in long range relation (3 bonds), respectively. HSQC 
and HMBC represent indirect detection techniques, which provide information on the 
relationship between signals from two different nuclei and enable in this way the 
elucidation of e.g. glycosides (Ratcliffe and Shachar-Hill, 2005). The acquisition of two-
dimensional advanced NMR spectra allows rapid mapping of spin networks yielding 
information on homotropic 1H - 1H and heterotropic 1H - 13C relations. However, the 
homotropic 13C - 13C relations will remain unknown, caused by the low abundance of 
natural 13C (Eisenreich and Bacher, 2007). 
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The increased information obtained from 2D NMR techniques carries the disadvantage 
of an increased acquisition time. This time penalty makes the 2D-experiments unsuitable 
for general routine high-throughput approaches. However, they provide important 
information for targeted and detailed investigations, e.g. metabolic profiling. (Ratcliffe and 
Shachar-Hill, 2005). 
The only 2D NMR method that can be employed as a metabolomic fingerprinting 
technique is 1H J-Resolved (J-Res) NMR. J-Resolved spectra unravel information on the 
1H - 1H coupling constant and the splitting pattern, while having a comparatively short 
acquisition time, relative to other 2D NMR techniques. (Ward et al., 2007). 
 
6.3 NMR and metabolomics  
1H NMR represents a powerful technique for the detection and definition of (new) 
metabolites, since any compound in the sample containing protons will give rise to specific 
signals. Therefore, it is widely used as a rapid metabolite fingerprinting and profiling 
technique to detect a broad range of metabolites in a generally non targeted way (Mattoli et 
al., 2006). Nuclear magnetic resonance spectrometry is a non-discriminative analytical 
method, therefore the spectra of plant tissue extracts provide information on the 
compounds present, covering compounds of all chemical classes (Colquhoun, 2007). In 
this way NMR spectrometry represents a useful tool for gaining an overall macroscopic 
view on the plant metabolome (Verpoorte et al., 2007). Compared to NMR spectrometry, 
where every single atom in a molecule is observed, other spectroscopic methods provide 
information of partial structural elements, and can therefore only be used for partial 
structural elucidation or the identification of already known metabolites (Verpoorte et al., 
2008). 
NMR is currently the method of choice for medical metabolomics (metabonomics). Its 
application for plant metabolomic analysis, however, has been more limited due to its 
lower sensitivity compared to MS-based techniques (Hall, 2006). The relatively poor 
sensitivity of NMR is the main drawback of this method, so that only metabolites present 
in a µM to mM range in the NMR tube can be detected (Colquhoun, 2007). Therefore 
NMR spectrometry represents a favored analytical tool for major metabolites, while many 
other compounds will typically be missed due to their occurrence in plant extracts below 
the NMR detection limit (Hall, 2006). However, this disadvantage is compensated by 
combination of the NMR-metabolomic data (fingerprinting) with a more targeted approach 
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for compounds of interest (profiling). In this way, a broad information on the metabolome 
can be obtained.  
NMR techniques show numerous advantages which can be considered complementary 
rather than competitive to other methods. Extracts can be measured directly by NMR 
spectrometry without a prior derivatization step. (Eisenreich and Bacher, 2007). NMR 
represents a non-destructive and non-discriminative analytical method unlike e.g. mass 
spectrometry, which depends on derivatization or the ability of compounds to ionize.(Ward 
et al., 2007) The possibility of unbiased quantitation represents a major advantage of 
NMR-acquired data, especially for metabolomics analyses (Verpoorte et al., 2008; 
Eisenreich and Bacher, 2007).  
The application of 1H and 13C NMR spectrometry for metabolic profiling of plant tissue 
extracts is well established. Its scope can be extended by introduction of an in-line liquid 
chromatography step prior to the NMR analysis and a parallel MS analysis. Liquid 
chromatography solves problems caused by overlapping signals and provides the 
possibility of concentrating minor metabolites by solid-phase extraction (SPE). Mass 
spectrometry gives additional complementary structural information. Although taking the 
NMR method further away from the metabolomic ideal of a rapid high-throughput single-
pass analytical tool, this approach provides a strategy for obtaining high-quality analytical 
information on pre-selected metabolite groups of interest (Ratcliffe and Shachar-Hill, 
2005). 
An NMR-spectrum represents a physical characteristic of the measured compound, and 
is therefore highly reproducible. This fact provides an important advantage, as it enables 
data mining from previous experiments, when following the same extraction procedures 
with the same NMR-solvents (Verpoorte et al., 2008). High reproducibility is also required 
for experiments studying the effect of external conditions on the plant metabolome, to 
define the biological variation. (Verpoorte et al., 2007).  
High resolution NMR spectrometry has become employed for the elucidation of 
biosynthetic pathways and metabolite flux with quantitative analyses of various 
isotopologues (Eisenreich and Bacher, 2007).  
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7. Multivariate Data Analysis  
 
7.1 General term definition  
In contrast to univariate statistical tests (e.g. t-test, analysis of variation = ANOVA), 
which are carried out on one variable (column) at a time, with multivariate methods all 
variables are considered simultaneously. To a data set with more than three variables 
multivariate data analysis (MVDA) is applied. The complexity of plant extracts results in 
highly complex spectral data, making a direct evaluation of the analytical significance 
challenging. Therefore, multivariate analyses are employed to ensure good analytical 
rigorousness and detect clusters of similarity or difference among the analyzed samples 
(Mattoli et al., 2006). In this way, conclusions can be drawn about the classification of 
individual plant samples (Ward et al., 2007). With multivariate analytical methods, 
datasets can be correllated, relative differences determined and visualized. In addition, the 
data can be interrogated to determine the metabolites causing the separation (Stewart et al., 
2007). 
The application of MVDA forms raw data to a statistic data set, which then allows 
further analysis. As such, MVDA does not represent a statistics method, as the treatment of 
the data does not aim towards prediction, but rather vizualization. The application of 
MVDA to a data set leads to significant data reduction, which is an essential requirement 
for comparison and classification of metabolic data (Ratcliffe and Shachar-Hill, 2005). 
 
7.2 Spectra processing  
Before multivariate analytical methods are applied to the spectral traces, the recorded 
spectra have to undergo preprocessing steps to re-shape the data. The processing consists 
of phasing, (manual/automatic) baseline correction, and calibration to a stable signal, 
solvent or internal standard [e.g. 3-(Trimethylsilyl)-propionic acid-d4 sodium salt, TSP], 
respectively. A computer software, e.g. xwin-nmr, TOPSPIN, is employed to perform 
these steps. 
 
  45
7.3 Alignment (binning or bucketing)  
The number of variables is reduced by the so-called bucketing procedure. The NMR 
spectrum is divided into bins (buckets) of a certain width, most commonly 0.04 ppm, 
summing (integrating) the intensities within each bin. The resulting bins are used as 
variables for further multivariate data analysis. This pretreatment step causes a certain loss 
of resolution, but results in a decrease of sample-to-sample variability and compensates 
pH-shifts. 
 
7.4 Scaling  
Prior to MVDA, data are standardized, in order to give the variables equal weight in the 
data analysis. Principal component analysis (PCA), as described in chapter 7.5, represents 
a maximum variance projection method. Hence, a variable with large variance will have 
more influence on the model than a low-variance variable.  
In order to balance the increased impact of variables with higher numerical ranges 
(bigger variance) on the model, the data are ”scaled”. By modifying the variance variables, 
it is possible to attribute different importance to them. This gives the possibility to down-
weight irrelevant or noisy variables.  
Normal spectroscopy data are mean-centered (Ctr), not scaled. For mean-centering, the 
average value of each variable is calculated and subtracted from the data. A disadvantage 
of this method is that minor signals might be ignored. The most common scaling 
technique, however, is the unit variance (UV) method. The mean centered variables 
(average subtracted) are divided by the standard deviation with the result that each scaled 
variable then has equal (unit) variance. This method enhances minor signals, and might 
cause exaggerated signal noise. Pareto scaling (Par) is in general the preferred option for 
metabolomics NMR-data. The centered variables are divided by SQRT(SD). This 
technique represents a compromise between the mean-centered method and unit variance 
(UV) scaling, enhancing minor signals (compounds) without significantly inflating 
baseline noise. 
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7.5 Principal component analysis (PCA)∗ 
Principal component analysis (PCA) represents the basic method of multivariate data 
analysis. It is an unsupervised multivariate projection method enabling to extract and 
visualize the variation in the analyzed data matrix. The term “unsupervised” indicates, that 
the experimental data alone are analyzed, without hypothesis, therefore providing unbiased 
information. The multivariate data set is represented in form of a low-dimensional plane,  
consisting of two to five dimensions (principal components), providing an overview of the 
acquired data. In this overview, groups of observations, trends, and outliers can be 
observed. Additionally, also relationships between observations and variables, and among 
the variables themselves are unraveled. 
PCA is a mathematical procedure, which serves to transform a variety of possibly 
correlated variables into a smaller number of uncorrelated variables - principal 
components. The first principal component (PC 1) accounts for as much of the variability 
in the data set as possible. The succeeding components account for the remaining 
variability. PCA therefore is a visualization method reducing the dimensionality of the data 
set. The resulting principal components represent descriptive dimensions indicating the 
maximum variation within the analyzed data set (Mattoli et al., 2006). 
The data matrix consists of observations in rows, and variables in columns. The 
observations can be analytical samples, chemical compounds or reactions, biological 
individuals, etc. Variables are measured in order to characterize the properties of the 
observations, using e.g. chromatographic methods (HPLC, GC, TLC,...) or other 
techniques, including NMR. Samples can be visualized as points in a multidimensional 
space with each variable forming an axis. PCA determines vectors in the multidimensional 
space of variables, indicating the direction of greatest dispersion of the samples by fitting 
the data as well as possible in the least square sense (Cuny et al., 2008).  
Before calculating the first principal component, the data are mean-centered, which 
results in a re-positioning of the coordinate system, such that the average point is the 
origin. Following mean-centering and scaling, the first principal component is calculated. 
PC 1 is the line that can approximate the data in the least square sense best and goes 
through the average point. It represents the maximum variance direction within the data. 
Each observation can be projected onto this line and get a co-ordinate value, named 
“score”.  
                                                 
∗ summary from Eriksson et al., Multi- and Megavariate Data Analysis (pp 43 – 69) 
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Usually, one principal component is not sufficient to depic the variation within a data 
set. Therefore, a second principal component (PC 2), represented by a line, which is 
orthogonal to PC 1 and passes through the average point, is calculated. Principal 
component 2, is oriented in a way, which represents the second largest source of variation 
in the data set. The most influential PCs are the first few, because they describe the greatest 
amount of variance. In this way, a great number of original variables is replaced by a small 
set of variables, principal components, without loss of information (Cuny et al., 2008). 
When dealing with plant material, the experimental design is of great importance. It is 
important to bear in mind that the main differences, revealed in principal component 1, can 
sometimes result from environmental effects (Ward et al., 2007). 
The first two principal components together define a plane. The observations can be 
projected onto this plane to vizualize the structure of the analyzed data set. The co-ordinate 
values of the observation on this plane are named “scores” and the plotting of this 
projected configuration forms a score plot. 
The third PC is oriented in the direction of the third largest variation in the data, is 
orthogonal to the first two principal components, and passes through the average point (the 
origin). The third principal component is perpendicular to the already existing model plane. 
The descriptive ability of a PC-model may improve by calculating more principal 
components. However, there is no rule and  several approaches to determine how many 
PCs are appropriate.  
The loading plot unravels information about the variables, which are responsible for the 
separation of observations in the score plot, influential variables and also their correlation. 
Variables comprising similar information are clustered - they are positively correlated. The 
increase or decrease of the numerical value of one variable tends to influence the numerical 
value of the other variable in the same way. In contrast to this, negatively (“inversely”) 
correlated variables are positioned on opposite sides of the plot origin, in diagonally 
opposed quadrants. The larger the distance of a variable to the plot origin, the stronger its 
influence on the model. The contribution factor of the principal components is calculated 
by the cosine of the angles, cos α. Values close to 1 (cos 0 = 1) indicate a strong influence, 
whereas values closer to 0 describe only little contribution (effect) of the PC. The principal 
component loadings give information of how the PC model plane is situated in the variable 
space. Loadings are used for interpretation of the scores. For the analysis a of loading plot, 
also column plot can be used, in which a higher signal (relative comparison) indicates 
bigger impact  on the model. 
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8. Material and physico-chemical methods 
 
8.1 Vaccinium macrocarpon extract 
8.1.1  Samples 
Five hundred gram of fresh American cranberry (Oceanspray) were purchased from the 
local market in Leiden (Netherlands) and stored at 4 °C. 
 
8.1.2 Extraction  
An amount of 340 g American cranberries (Vaccinium macrocarpon), cut in half, was 
extracted by maceration with 600 ml 80% methanol, under sonication for 30 min. The solid 
parts were separated by vacuum tank filter and the methanol fraction was evaporated until 
dryness. The addition of few drops of n-butanol was used to decrease the boiling 
temperature. The dried extract was reconstituted in 50 ml Millipore water. This aqueous 
phase was extracted three times with 50 ml ethyl acetate. The ethyl acetate fractions were 
collected in a flask and sodium sulfate was added to remove residual water in the organic 
fraction. The ethyl acetate phase was evaporated until dryness and reconstituted in ca. 5 ml 
methanol.   
 
8.1.3  Separation 
The methanol extract of V. macrocarpon was loaded onto a Sephadex LH-20 column. 
Degassed methanol was used as eluent and 77 fractions were collected. 
 
8.1.4 Thin Layer Chromatography (TLC) 
The collected fractions were analyzed by TLC on Silica gel plate. The mobile phase was 
a mixture of ethyl acetate, formic acid, acetic acid and water 100:11:11:27 (v/v). The 
compounds were detected under UV 254 nm and 366 nm. Fractions showing the same 
pattern under UV were pooled and resulted in 7 new fractions. The pooling scheme is 
depicted in Tab. 4. 
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fraction 1 1 – 23 
fraction 2 24 – 31 
fraction 3 32 – 39 
fraction 4 40 – 44 
fraction 5 45, 46 
fraction 6 47, 48 
fraction 7 49 - 55 
Tab. 4. Pooling of Sephadex fractions 
 
8.1.5  NMR Sample Preparation 
The dried sample was reconstituted in 1 ml deuterated NMR solvent, CD3OD, 
sonicated to improve the solubility and centrifuged (13 000 rpm). Eight hundred µl of the 
supernatant were transferred in a 5 mm NMR-tube and ¹H-NMR-spectra were acquired at 
Bruker, 500MHz. For fractions 4 and 6, also following two-dimensional NMR-spectra 
were recorded: J-resolved, COSY, HMBC. 
 
8.1.6 Spectra Processing (xwin-nmr) 
Preprocessing steps of the NMR spectra were performed with xwin-nmr software 
(Bruker), consisting of phasing, baseline correction and calibration (on methanol signal → 
3,3 ppm). All processing was done by manual. 
 
8.1.7 High Performance Liquid Chromatography (HPLC) 
Sephadex fraction 5 showed a complex ¹H-NMR spectrum, which suggested that it 
obviously contained several phenolic / flavonoid compounds, resulting in peak overlap. 
Preparative HPLC was chosen as a second separation step, based mainly on polarity of the 
compounds. For HPLC, reversed phase column (Phenomenex  Luna C18, 5  250 x 10 
mm) was applied using a solvent system A: 0.1% formic acid in methanol, B: 0.1% formic 
acid in water in the ratio of 60:40, run 26 min isocratically. Automatic fraction collection 
(Agilent Technologies 1200 series) was used, 48 fractions (à 2 ml) were collected. Elutions 
were detected using UV spectrometry (Agilent Interface 35900E) at 254 nm, 220 nm, 280 
nm, 360 nm. Fractions representing one peak were pooled (see Tab. 5), prepared for NMR 
measurement, according to protocol described in 8.1.5, and ¹H-NMR spectra acquired. 
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fraction 5A 27 – 34 
fraction 5B 35 – 39 
fraction 5C 40 – 43 
fraction 5D 44 
fraction 5E 45 - 48  
Tab. 5. Pooling of HPLC fractions 
 
 
8.2 Cranberry Juice 
8.2.1 Samples  
Four different brands of pure cranberry juices were analyzed, which were purchased at 
local supermarkets in Leiden, Netherlands. Two batches per brand were obtained. 
 
 Juice (volume) Declared content 
1 Oceanspray cranberry classic juice drink          
(1 l)               
water, cranberry juice 25%, fructose-
glucose syrup, antioxidant: ascorbic acid 
0.03 
2 Cranberryjuice lightly sweetened (0,75 l) cranberry juice 95%, fructose-glucose 
syrup 5%, pasteurized 
3 Cranberryjuice pure and not sweetened  
(1 l)      
cranberry juice 100%, concentrate of 
preservative 
4 Natufood cranberryjuice (0.33l ) cranberry juice 100% 
Tab. 6. Juices and declared content 
 
 
Juice Batch Expiration date Sample – ID 
    
1 L064 C233T  12.08 CRJ 1A 
 L064 C057T   12.08 CRJ 1B 
 n.a.*  07.05 CRJ 1C 
    
2 n.a.*  18.11.09 CRJ 2A 
 n.a.* 25.12.09 CRJ 2B 
    
3 n.a.*   13.1.10 CRJ 3A 
 n.a.* 5.3.10 CRJ 3B 
    
4 EL 29296  1.2.10 CRJ 4A 
 DL 29559  15.2.10 CRJ 4B 
Tab. 7. Cranberry juice details (* batch number not declared on juice 
 package; batch difference ensured by purchasing these juices at different  
 time points in different supermarkets.) 
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8.2.2 Sample Preparation 
The goal was to find a suited extraction method to remove unwanted primary 
metabolites, such as sugar and organic acids, which are present in relatively high 
concentrations, and to concentrate flavonoids to allow their analysis. 
 
8.2.2.1 Direct measurement 
Five hundred µl of KH2PO4-buffer/D2O (1:1, v/v) were added to 500 µl CRJ1A – 4B in 
an eppendorf tube and vortexted 1 min. After centrifugation (13 000 rpm, 5 min), 800 µl of 
the supernatant were transferred into a 5 mm NMR-tube and ¹H-NMR spectra were 
acquired at Bruker, 500 MHz, using water suppression mode. 
 
8.2.2.2 Extraction with ethyl acetate 
Four ml of CRJ1A – 4B were extracted with 4 ml ethyl acetate by vortexing for 1 min 
in a small test tube, twice. The ethyl acetate phases were collected and residual water in the 
organic phase was removed by sodium sulfate. After evaporation of the ethyl acetate, the 
dried extract was reconstituted in 1 ml MeOD and centrifuged (13 000 rpm, 5 min). Eight 
hundred µl of the supernatant were transferred into a 5 mm NMR-tube and ¹H-NMR 
spectra were acquired at Bruker, 500 MHz. 
 
8.2.2.3 Extraction with ethyl acetate after neutralization 
pH of the juice samples (CRJ1A – 4B) was adjusted with 1 M NaOH, using a pH-meter. 
A change of color from bright red to green - brown was observed as the juices approached 
neutral pH. With the neutralized juices, the extraction protocol using ethyl acetate, 
described under 8.2.2.2 was followed.  
The dried extracts were reconstituted both in MeOD and MD 6 to check which NMR-
solvent was most suitable. ¹H- and J-resolved spectra were recorded at Bruker, 600 MHz, 
cryoprobe. Triplicates of each sample were analyzed. 
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cranberry juice sample pH (temperature) after adjustment 
CRJ 1A 2.72 (23.8°C) 7.08 
CRJ 1B 2.70 (23.5°C) 7.01 
CRJ 1C 2.67 (24.5°C) 7.09 
CRJ 2A 2.42 (23.5°C) 7.03 
CRJ 2B 2.43 (23.5°C) 7.13 
CRJ 3A 2.44 (23.6°C) 7.08 
CRJ 3B 2.42 (24.0°C) 7.02 
CRJ 4A 2.61 (24.2°C) 6.93 
CRJ 4B 2.60 (24.0°C) 7.07 
Tab. 8. Juice pH before and after adjustment 
 
8.2.2.4 Solid Phase Extraction 
Four ml of CRJ 3A (chosen sample for preliminary extraction tests) were loaded onto a 
SepPak Cartridge (C18, RP, 1 cm) and eluted with: 
a) water, 25%, 50%, 75%, 100% MeOH (à 4 ml) 
b) water, 100% MeOH (à 4 ml) 
 
The fractions were collected and evaporated. The dried extracts were reconstituted in 1 
ml NMR-solvent, which was chosen dependent on their solubility, and transferred in an 
eppendorf tube. 
 
Fraction.................................................................  NMR solvent 
25%, 50%, 75% MeOH…………………………. MD 6 
Water……………………………………………. D2O 
100% MeOH.........................................................  MeOD 
 
After centrifugation (13 000 rpm, 5 min), 800 µl of the supernatant were transferred in a 
5 mm NMR-tube and ¹H-NMR spectra were acquired at Bruker, 500MHz. 
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8.2.3 Preprocessing and PCA analysis  
The NMR data were automatically reduced to ASCII files using AMIX (Bruker 
Biospin). The spectral intensities were reduced to integrated regions of the equal width of 
0.04 ppm (buckets or bins) corresponding to the region of 10.0 to -0.1 ppm. The residual 
water and methanol signals were excluded. The files were imported into Excel files and 
transferred to SIMCA-P (11.0 Umetrics). Prior to PCA analysis, pareto scaling (Par) was 
applied to the data set, as it enhances small signals without inflating baseline noise. PCA 
was carried out on spectral data, which consist of the buckets representing the phenolic 
region of the ¹H-NMR-spectra (5.5 – 8.5 ppm) of all analyzed samples. 
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9. Results and Discussion 
 
9.1 Vaccinium macrocarpon extract 
 
The compounds present in the extract were elucidated based on the acquired one- and 
two dimensional NMR-spectra from the 7 Sephadex fractions (see Appendix), combined 
with information from literature related to phenolics / flavonoids in V. macrocarpon. The 
structures of the main phenolic / aromatic compounds are listed in Tab. 9. 
 
Fraction Metabolites Chemical shifts (ppm) and coupling constants (Hz) 
   
1 Benzoic  
acid glucoside* 
δ 8.10 (H-2, H-6, d),  δ 7.63 (H-4, t), δ 7.50 (H-3, H-5, 
t), 5.71 (H-1’, d) 
   
2 Citric acid δ 2.95 (H-β, d), δ 2.83 (H-β’, d) 
 Malic acid δ 4.50 (H-α, dd), δ 2.85 (H-β, dd), δ 2.60 (H-β’, dd) 
   
3 Chlorogenic acid δ 7.58 (H-7’, d), δ 7.03 (H-2’, d), δ 6.98 (H-6’, d), δ 
6.92 (H-5’, d), δ 6.30 (H-8’, d), δ 5.35 (H-3, td), δ 4.10, 
δ 3.70 (H-4, dd), δ 2.15 (H-2β, H-6β, m), δ 2.00 (H-2α, 
H-6α, m) 
   
4 Rutin δ 7.65 (H-2’, d, J = 2.0 Hz), δ 7.58 (H-6’, dd, J = 2.0, 
8.5 Hz), δ 6.93 (H-5, d, J = 8.5 Hz), δ 6.42 (H-8, d, J = 
2.0 Hz), δ 6.20 (H-6, d, J = 2.0 Hz), δ 5.2 (H-1’’, d, J = 
7.8 Hz), δ 0.99 (H-6’’’, d, J = 6.1 Hz) 
 Myricetin-glucoside* δ 7.57 (H-2’ and H-6’, s), δ 6.41 (H-8, d, J = 2.1 Hz), δ 
6.21 (H-6, d, J = 2.1 Hz) 
 Myricetin  δ 7.35 (H-2’ and H-6’, s), δ 6.40 (H-6, d, J = 2.0 Hz), δ 
6.20 (H-8, d, J = 2.0 Hz) 
 Quercetin-3-O-
rhamnoside  
(Quercitrin) 
δ 7.33 (H2’, d, J = 2.0 Hz), δ 7.30 (H-6’, dd, J = 1.9, 
7.9 Hz), δ 6.90 (H-5, d, J = 8.2 Hz), δ 6.37 (H-8, d, J = 
2.0 Hz), δ 6.20 (H-6, d, J = 2.2 Hz), δ 5.39 (H-1’’, d, J 
= 2.1 Hz), δ 0.99 (H-6’’, d, J = 6.1 Hz) 
 Kaempferol  δ 8.08 (H-2’ and H-6’,d, J = 9.0 Hz), δ 6.85 ( H-3’ and 
H-5’, d, J = 8.5), δ 6.42 ( H-8,d, J = 2.1 Hz), δ 6.22 ( 
H-6, d, J = 2.1 Hz) 
   
5 Epicatechin δ 6.97 (H-2’, d), δ 6.80 (H-6’, dd), δ 6.75 (H-5’, d), δ 
5.98 (H-6, d), δ 5.92 (H-8, d), δ 4.22 (H-3, m), δ 2.90 
(H-4α, dd), δ 2.77 (H-4β, dd) 
 Quercetin-3-O-
rhamnoside 
(Quercitrin) 
δ 7.33 (H-2’, d), δ 7.30 (H-6’, dd), δ 6.90 (H-5, d), δ 
6.37 (H-8, d), δ 6.20 (H-6, d), δ 5.39 (H-1’’, d), δ 0.99 
(H-6’’, d) 
 Quercetin-3-O-
glucoside 
δ 7.83 (H-2’, d),  δ 7.58 (H-6’, dd), δ 6.87 (H-5’, d), δ 
6.40 (H-8, d), δ 6.20 (H-6, d), δ 5.20 (H-1’’, d) 
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6 Epicatechin δ 6.97 (H-2’, d,), δ 6.78 (H-6’, dd), δ 6.73 (H-5’, d), δ 
6.00 (H-6, d), δ 5.98 (H-8, d), δ 4.35 (H-2, d) δ 4.22 
(H-3, m), δ 2.85 (H-4α, dd), δ 2.77 (H-4β, dd) 
 Quercetin-3-O-
glucoside 
δ 7.83 (H-2’, d, J = 2.1 Hz),  δ 7.58 (H-6’, dd, J = 2.0, 
8.6 Hz), δ 6.87 (H-5’, d, J = 8.5 Hz), δ 6.40 (H-8, d, J = 
2.1 Hz), δ 6.20 (H-6, d, J = 2.1 Hz), δ 5.20 (H-1’’, d, J 
= 7.8 Hz) 
 Quercetin-glycoside* δ 7.52 (H-2’, d, J = 2.1 Hz), δ 7.49 (H-6’, dd, J = 2.1, 
8.5 Hz), δ 6.89 (H-5’, d, J = 8.5 Hz), δ 6.40 (H-8, d, J = 
2.1 Hz), δ 6.20 (H-6, d, J = 2.1 Hz) 
   
7 Gallic acid δ 7.12 (s) 
 Quercetin-glycoside* δ 7.52 (H-2’, d), δ 7.49 (H-6’, dd), δ 6.89 (H-5’, dd), δ 
6.40 (H-8, d), δ 6.20 (H-6, d) 
 Myricetin δ 7.37 (H-2’ and H-6’, s), δ 6.40 (H-8, d), δ 6.20 (H-6, 
d) 
Tab. 9. Phenolic/flavonoid compounds in V. macrocarpon extract  
(*confirmation by 2D-NMR needed) 
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9.2 Cranberry Juice Analysis 
9.2.1 Extraction methods 
Several extraction methods of the juice samples, which are described in chapter 8.2.2., 
were tried to remove unwanted primary metabolites, as sugar and organic acids and to 
concentrate the phenolic / flavonoids to allow their analysis. 
 
9.2.1.1 Direct measurement 
The juice samples were measured without any concentration step, directly after dilution 
with NMR-solvent, buffer/D2O (1:1). The acquired spectra (Fig. 5.) show peaks of high 
intensity in the aliphatic region (3 – 5 ppm), representing α- and β-glucose and the organic 
acids, citric and malic acid, respectively. Hardly any peaks could be observed in the 
phenolic region (5.5 – 8.5 ppm). Cranberry juice contained high concentration of sugar and 
organic acids in relation to the phenolic compounds. Therefore, the juice samples could not 
be measured directly to analyze their phenolic secondary metabolites. Extraction was 
required to concentrate the compounds of interest.  
 
 
Fig. 5. 1H-NMR_direct measurement 
 
β-Glucose 
Citric acid 
Malic acid 
α-Glucose 
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9.2.1.2 Extraction with ethyl acetate 
By extraction with ethyl acetate (Fig. 6.), sugars were removed quantitatively, but still 
high concentrations of citric and malic acid were present in the extract. The only 
significant, though still minor signals in the phenolic region, could be assigned to the 
structure of benzoic acid. Benzoic acid is used in the beverage industry as antioxidant and 
preservative. The applied extraction method with ethyl acetate did not lead to satisfactory 
results, as it was not able to remove all primary metabolites. The high concentration of 
organic acids did not allow the detection of the phenolic secondary metabolites, which 
were present in lower concentration. 
 
Fig. 6. 1H-NMR_EtOAc-extraction 
 
9.2.1.3 Solid Phase Extraction 
Sugars were eluted in the water fraction (Fig. 7.). In the methanol fraction (Fig. 8.), no 
peaks in the phenolic region could be observed, the extraction-/concentration method for 
phenolic secondary metabolites was not successful. This might be explained by fact that 
interaction between solid and mobile phase is influenced by the pH of the loaded sample. 
The pH of the analyzed cranberry juices was between 2.4 and 2.7 due to the high content 
of organic acids, which could be responsible for the ineffectiveness of SEP concerning 
concentration of the phenolic compounds, in this case. 
 
 Malic acid 
MeOH 
Citric acid 
EtOAc 
Benzoic acid 
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Fig. 7.  1H-NMR_SPE_water 
 
 
Fig. 8. 1H-NMR_SPE_MeOH 
 
9.2.1.4 Extraction with ethyl acetate after neutralization 
Prior to extraction with ethyl acetate, pH was adjusted to 7 ± 0.2 using 1 M NaOH. Due 
to the neutral pH, organic acids were brought into their ionic form and therefore stayed in 
the aqueous phase. Phenolic secondary metabolites could be extracted in the ethyl acetate 
phase. In this way, a separation of primary and secondary metabolites was obtained, with 
primary metabolites (sugar, organic acids) in the aqueous, and secondary metabolites 
α-Glucose 
β-Glucose 
MeOH 
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(flavonoids) in the ethyl acetate phase. Fig. 9. and Fig. 10. show a zoom in the phenolic 
region of ¹H-spectra recorded from these extracts (5.5 – 8.5 ppm). The extraction method 
gave rise to a number of peaks, representing phenolic secondary metabolites. The 
experiment was carried out with MeOD and MD 6 as NMR-solvents, to study in which 
solvent the extracted compounds were better soluble and therefore provided the better 
spectrum. The two spectra were comparable concerning their resolution, quality and 
quantity of peaks. MD 6 was chosen as the NMR-solvent to be used for all samples, as it 
provided some advantages. It contained KH2PO4 buffer (pH 6), and in this way contributed 
to the stability of the pH, which was shown to represent an important factor. It also 
contained 0.1% TSP as internal standard, which was used for calibration. A database of 
NMR-spectra with compounds of interest contained ¹H-spectra recorded in MD 6, and 
spectra could be directly compared, as compounds measured in the same solvent are 
expected to show peaks at the same chemical shifts. 
 
 
 
Fig. 9. 1H-NMR_EtOAc_pH7_MD6 
 
 
Fig. 10. 1H-NMR_EtOAc_pH7_MeOD 
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9.2.2 Multivariate Data Analysis 
Principal Component Analysis (PCA) was employed as an unsupervised multivariate 
data analysis method to gain an overview about the relation between the analyzed juice 
samples. Only the aromatic region of the measured spectra (5.5 – 8.5 ppm) was considered 
in the calculation, to compare the saples in respect to their phenolic / flavonoid profile.  
The analyzed cranberry juice samples have shown to provide significant differences to be 
clearly separated in the score scatter plot (Fig.11.). Three groups were obtained by 
employing principal component 1 (PC 1) vs. principal component 2 (PC 2) for the 
separation.  
 
 
 
Fig. 11. Principal component analysis – score plot (PC 1 vs. PC 2) 
 
 
 
Group Sample Juice 
   
1 4A, 4B Natufood cranberryjuice 
 4B Natufood cranberryjuice 
   
2 1A, 1B, 1C Oceanspray cranberry classic juice drink 
   
3 2A, 2B Cranberryjuice lightly sweetened 
 3A, 3B Cranberryjuice pure and not sweetened 
Tab. 11. Sample ID; grouping in the score plot 
1 
2 
3 
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In the loading plot (Fig. 12., Fig. 13.), the contribution of metabolites to the separation 
of the samples is revealed. The higher the column, the higher the impact on the model. 
Structures of compounds represented by the columns could be identified and an overview 
about differentiating compouds in the juice samples and concentration trends is given in 
Tab. 13. 
 
 
 
          Fig. 12. Principal component analysis – loading plot for PC 1 
 
 
 
 
 
          Fig. 13. Principal component analysis – loading plot for PC 2 
 
1 
1 1 
2 2 
2 
3 3 3 
1 
4 
5 5 
4 
4 
3 
4 
1 
1 
  62 
 
 Metabolite Chemical shift (ppm) and coupling constant (Hz) 
1 Benzoic acid glucoside δ 8.12 (H-2 and H-6, d, J = 8.0 Hz), δ 7.73 (H-4, t), δ 7.58 
(H-3 and H-5, t), 5.78 (H-1’, d, J = 8.0 Hz) 
2 Benzoic acid δ 7.90 (H-2 and H-6, d, J = 8.0 Hz), δ 7.49 (H-4, t), δ 7. 43 
(H-3 and H-5, t) 
3 Quercetin δ 7.76 (H-2’, d, J = 2.0 Hz), δ 7.67 (H-6’, dd, J = 2.0, 8.5 
Hz), δ 7.00 (H-5’, d, J = 8.5 Hz), δ 6.50 (H-6, d, J = 2.0 
Hz), δ 6.31 (H-8, d, J = 2.0 Hz) 
4 Catechin  δ 2.54 (H-4β, dd), δ 2.84 (H-4α, dd), δ 4.10 (H-3, ddd), δ 
4.69 (H-2, d), δ 5.97 (H-8, d), δ 6.04 (H-6, d), δ 6.80 (H-
6’, dd), δ 6.87 (H-5’, d), δ 6.90 (H-2’, d)  
5 Myricetin  δ 7.36 (H-2’ and H-6’, s), δ 6.52 (H-6, d, J = 2.0 Hz), δ 
6.30 (H-8, d, J = 2.0 Hz) 
6 Quercitrin δ 7.38 (H-2’, d, J = 2.0 Hz), δ 7.35 (H-6’, dd, J = 2.0, 8.5 
Hz), δ 7.03 (H-5’, d, J = 8.5 Hz), δ 6.50 (H-6, d, J = 2.0 
Hz), δ 6.31 (H-8, d, J = 2.0 Hz), δ 5.29 (H-1’’), δ 0.92 (H-
6’’, d, J = 6.2 Hz) 
7 Kaempferol  δ 8.08 (H-2’ and H-6’, dd, J = 1.5, 8.0 Hz), δ 7.10 (H-3’ 
and H-5’, dd, J = 8.5 Hz), δ 6.48 (H-6, d, J = 2.0 Hz), δ 
6.30 (H-8, d, J = 2.0 Hz) 
Tab. 12  Compounds present in the analyzed cranberry juices 
 
 
Sample Characteristic  
  
1A, 1B, 1C Benzoic acid ↓, Myricetin ↑, Benzoic acid glucoside ↑ 
  
2A, 2B, 3A, 3B Benzoic acid ↑ 
 Quercetin ↑ 
 Kaempferol ↑ 
  
4A, 4B Benzoic acid glucoside ↑ 
 Catechin ↑ 
Tab. 13. Concentration trends of differentiating compounds in the 3 groups 
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9.3 Discussion 
 
9.3.1. Cranberry extract 
The analysis of a cranberry extract had the pursuit of metabolite identification, using 
NMR. The extraction with 80% methanol and ethyl acetate allowed a concentration of the 
phenolic / flavonoid compounds of cranberry. There was no hydrolysis step in the 
extraction protocol, therefore, flavonoids could be detected in their glycosylated form.  
The direct NMR-measurement of the pure cranberry extract would result in a complex 
and overfilled spectrum due to major peak overlap. Therefore, a Sephadex LH-20 column 
was chosen for the separation of the phenolic compounds, which could subsequently be 
observed on a TLC-plate under UV. According to the flavonoid pattern observed, the 
collected fractions were pooled. For the resulting 7 fractions, NMR-spectra were recorded. 
For Sephadex fraction 5, additional separation by HPLC followed, due to its complex 1H-
NMR spectrum. 
The applied methods allowed the identification of the main phenolic compounds in a 
mixture, by measuring one- and two-dimensional NMR-spectra of the 7 Sephadex fractions 
obtained. The first 3 fractions contained mainly acids: benzoic acid glucoside, citric, malic 
and chlorogenic acid. In fractions four-seven, flavonoids were eluted and identified as 
rutin, quercetin-3-O-glucoside, quercitrin, myricetin, epicatechin. Moreover, other 
quercetin-glycosides were be detected. Further 2D-NMR measurements (HMBC) would be 
necessary for their exact structure elucidation. 
 
9.3.2. Cranberry juice 
Different extraction methods of the cranberry juice cocktail were performed and 
compared. The extraction of the neutralized juice with ethylacetate was chosen, and used 
for all samples, as it provided a good separation of the primary metabolites (sugar, acids) 
and was able to concentrate the secondary phenolic metabolites present.  
1H- and J-Resolved NMR spectra of the extracts were recorded at 600MHz, and 
principal component analysis was applied to the aromatic regions (5.5 – 8.5 ppm) of the 
obtained spectra. Three well separated clusters could be observed in the score scatter plot 
(Fig. 11.), originating from 4 cranberry juice samples analyzed. The best separation was 
obtained using principal component 1 (PC 1) vs. principal component 2 (PC 2). The 
formation of three groups (in contrast to four groups expected, due to four cranberry juices 
analyzed) might be explained by the fact, that the juice samples 2A, 2B, 3A and 3B 
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originated from one brand and differed only in their declared sugar content (“lighly 
sweetened” vs. “pure and not sweetened”, see Tab. 6.). Sugars were removed by extraction 
with ethyl acetate and only the aromatic region of the 1H-NMR spectra (5.5 – 8.5 ppm) was 
considered in the multivariate data analysis. Therefore, these samples formed only one 
cluster in the score scatter plot (Fig. 11.: group 3). 
PC 1 separated group 1 from group 2 by the relatively higher concentration of benzoic 
acid glucoside and myricetin in the samples 1A, 1B, 1C (group 2) and the relatively higher 
amount of benzoic acid and catechin in the samples of group 1 (samples 4A, 4B). Principal 
component 2 induced a separation of group 1 and group 3. The separation criteria were the 
relatively higher concentration of benzoic acid glucoside and catechin in group 4 and the 
relatively higher amounts of benzoic acid and quercetin in group 3.  
PCA was shown to be successful in differentiating the analyzed cranberry juices by in 
regard to their phenolic content only. Benzoic acid, benzoic acid glucoside, quercetin, and 
catechin were found to be the main sources of difference in the analyzed juice samples, 
which were revealed in the loading plot. The identification of the compounds was 
facilitated by the previous analysis (identification) of phenolic metabolites in a cranberry 
extract.  
The reproducibility of the experiment was satisfactory, shown by clear clustering of the 
replicates. No outliers were observed. Sample 1C, an old and expired juice, was slightly, 
but clearly separated from the other samples from this brand (1A and 1B). 
Nuclear magnetic resonance spectrometry (NMR) was shown to represent a fast and 
effective method for the characterization of the complex chemical composition of 
cranberry juice cocktail. It allowed the detection of a large number of compounds, present 
in a wide range of concentrations, with relatively little and fast sample preparation. Being a 
macroscopic method, NMR has, unlike other analytical methods, a broad scope, which 
allows the observation of not only the flavonoid content, but also changes/differences of 
other quality-contributing compounds. In this way, not only the flavonoid content could be 
monitored, but also adulterations, such as preservative addition could be detected. The 
experiments were carried out without a hydrolysis step in the protocol, therefore, flavonoid 
glycosides were detected, facilitated by two-dimensional NMR spectrometry. The art and 
degree of glycosylation significantly affect the antioxidant capacity and in this way also 
strongly  the quality of cranberry juice and represents therefore an important factor to be 
well studied in the quality control of cranberry juice cocktails. 
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Interestingly, no proanthocyanidins (PACs) could be detected, neither in the cranberry 
extract, nor in any of the analyzed juice cocktails. Possible explanations might be low 
concentrations of the PACs compared to the relatively high detection limit of NMR 
spectrometry or an improvable extraction method (solvent / pH). Detection of the bioactive 
PACs, would be essential for the establishment of a quality control method of cranberry 
juice.  
The applied method was successful  in identification of differentiating phenolic 
compounds in cranberry juice cocktails, but no conclusions could be made about their 
impact on the quality of these juices. No definition of a “high-quality” cranberry juice 
cocktail, has been given yet.  
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10. Summary 
Consumption of cranberry juice cocktails is often recommended for the prevention of 
urinary tract infections (UTIs), which affect mainly women in all age groups. Clinical 
studies show a positive correlation between ingestion of cranberry juice and a decreased 
incidence of UTIs. Foo et al. (2000) elucidated the structures of the bioactive compounds, 
being fructose and proanthocyanidins (condensed tannins) – phenolic secondary 
metabolites of American cranberry, which are responsible for the antiadhesive effect of 
cranberry juice against E. coli, the most common uropathogen. In this way becoming a 
health-promoting product, the quality of cranberry juice, especially regarding the active 
compounds (phenolic secondary metabolites) needs to be monitored. 
The composition of phenolic secondary metabolites was studied in an extract of 
American cranberries using NMR spectrometry, with the aim to identify the main phenolic 
/ flavonoid compounds,. The extract was subjected to a separation on a Sephadex LH-20 
column, and 1H-NMR spectra were recorded for the 7 resulting fractions, enabling the 
identification of benzoic acid glucoside, malic, citric and chlorogenic acid, rutin, quercetin-
3-O-glucoside, quercitrin, myricetin, epicatechin and kaempferol. 
Subsequently, cranberry juice cocktails originating from four different manufacturers 
were extracted and subjected to 1H-NMR analysis. Principal component analysis was 
employed to detect differences in the phenolic / flavonoid profiles of the analyzed juice 
samples. The samples formed three clusters in the score scatter plot, which might be 
explained by the fact that two of the samples originated from one brand and differed only 
in the declared sugar content. Sugar was removed in the extraction procedure and only the 
aromatic region of the 1H-NMR spectra was considered in the PCA analysis, therefore 
these samples form one group. The differentiating compounds between the three groups 
could be identified more easily on the basis of the former analysis of an American 
cranberry extract, as: benzoic acid glucoside, benzoic acid, quercetin and catechin. 
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11. Zusammenfassung 
Basierend auf seiner volksmedizinischen Verwendung wird Cranberrysaft zur 
Prophylaxe von Harnwegsenzündungen, die vorwiegend Frauen aller Altersstufen 
betreffen, empfohlen. Einige klinische Studien konnten einen positiven Effekt von 
Cranberrysaft durch geringere Häufigkeit des Auftretens von Harnwegsinfektionen zeigen. 
Als wirksame Inhaltsstoffe gelten Fructose und Proanthocyanidine (kondensierte Tannine) 
– phenolische Sekundärmetaboliten von Vaccinium macrocarpon (Amerikanische 
Cranberry). Sie vermitteln dem Cranberrysaft antiadhäsive Eigenschaften gegen E. coli, 
dem häufigsten Erreger von Harnwegsinfektionen und unterbinden so seine Pathogenität. 
Cranberrysaft wird auf diese Weise zu einem gesundheitsfördernden 
Nahrungsergänzungsmittel, dessen Qualität, besonders hinsichtlich der bioaktiven 
phenolischen Sekundärmetaboliten, kontrolliert werden sollte. 
Die Zusammensetzung der phenolischen Sekundärmetaboliten wurde in einem Extrakt 
Amerikanischer Cranberry untersucht, mit dem Ziel, die quantitativ wichtigsten 
phenolischen / flavonoiden Inhaltsstoffe zu identifizieren. Zur Auftrennung der 
Inhaltsstoffe wurde der Extrakt auf eine Sephadex LH-20 Säule aufgetragen und die daraus 
resultierenden sieben Sammelfraktionen wurden mittels 1H-NMR Spektroskopie analysiert. 
Die freien Säuren Benzoesäure-Glucosid, Apfel-, Zitronen- und Chlorogensäure und die 
Flavonoide Rutin, Quercetin-3-O-Glucosid, Quercitrin, Myricetin, Epicatechin und 
Kämfperol, konnten identifiziert werden. 
Anschließend wurden Cranberrysäfte, die von vier verschiedenen Herstellern stammten, 
extrahiert und einer 1H-NMR Analyse unterzogen. Principal Component Analysis (PCA) 
wurde als multivariate Datenanalyse-Methode verwendet, um Unterschiede zwischen den 
untersuchten Proben darzustellen. Die Cranberrysaft-Proben bildeten drei Gruppen im 
Score Scatter Plot. Das kann dadurch erklärt werden, dass zwei der untersuchten Proben 
vom gleichen Hersteller stammten, und sich nur im deklarierten Zuckergehalt 
unterschieden. Durch die Extraktion wurde Zucker quantitativ abgetrennt und nur die 
aromatische Region der NMR-spektren (5.5 – 8.5 ppm) für die PCA Analyse 
herangezogen. Daher bildeten diese Proben eine Gruppe. 
Die Strukturaufklärung der Unterscheidungsmerkmale zwischen den Cranberrysäften 
wurde durch die vorangegangene Analyse eines Cranberry-Extraktes erleichtert. Die 
untersuchten Cranberrysäfte zeigten unterschiedliche Konzentrationen von Benzoesäure-
Glucosid, Benzoesärue, Quercetin und Catechin. 
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1H-NMR spectra of Sephadex fractions of a Vaccinium macrocarpon extract (1 – 7) 
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